Dr. Vicente Soriano

Contact

All Stories

Increased Cases and Deaths from Listeria Infections in Spain

Article • International Journal of Infectious Diseases, August 2024, Elsevier

Dr. Vicente Soriano, Octavio Corral Pazos de Provens
Prevalence of HTLV-1/2 infection in pregnant women in Central and South America and the Caribbean: a systematic review and meta-analysis

Article • International Journal of Infectious Diseases, June 2024, Elsevier

Dr. Vicente Soriano
COVID-19 mortality amongst the immunosuppresed

Article • Journal of Infection, April 2024, Elsevier

Dr. Vicente Soriano
Prospects for Controlling Hepatitis B Globally

Article • Pathogens, March 2024, MDPI AG

Dr. Vicente Soriano
Human T-lymphotropic virus-1 infection among Latin American pregnant women living in Spain

Article • IJID Regions, March 2024, Elsevier

Dr. Vicente Soriano
Screening for HTLV-1 infection should be expanded in Europe

Article • International Journal of Infectious Diseases, February 2024, Elsevier

Dr. Vicente Soriano
Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients

Article • January 2024, Cold Spring Harbor Laboratory Press

Dr. Vicente Soriano
Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)

Article • NeuroImmune Pharmacology and Therapeutics, January 2024, De Gruyter

Dr. Vicente Soriano
�One Health�: toward an integral ecology of health

Article • Aids Reviews, January 2024, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals

Article • Aids Reviews, January 2024, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Testing a vaccine candidate against Hepatitis C virus designed by combinatorial optimization

Article • Scientific Reports, December 2023, Springer Science + Business Media

Dr. Vicente Soriano
HTLV infection in persons with sexually transmitted diseases in Spain

Article • Frontiers in Immunology, December 2023, Frontiers

Dr. Vicente Soriano
HTLV-1-associated myelopathy in Spain

Article • Journal of Clinical Virology, December 2023, Elsevier

Dr. Vicente Soriano
Triple Threat: HDV, HBV, HIV Coinfection

Article • Clinics in Liver Disease, November 2023, Elsevier

Dr. Vicente Soriano
HTLV European Research Network 2023: the silent pandemic of HTLV-1 infection

Article • Aids Reviews, October 2023, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Mitochondrial damage as cause of long COVID

Article • Aids Reviews, October 2023, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Rebound in sexually transmitted infections after the COVID-19 pandemic

Article • Aids Reviews, October 2023, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Genetic Changes in T Cell Receptors May Explain Severe COVID-19 Cases

Article • iScience, October 2023, Elsevier

Professor Jose M Martin-Villa, Dr. Vicente Soriano, Octavio Corral Pazos de Provens
Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain

Article • Journal of Clinical Virology, October 2023, Elsevier

Dr. Vicente Soriano
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

Article • Journal of Clinical Virology, October 2023, Elsevier

Dr. Vicente Soriano
Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection

Article • Advanced Drug Delivery Reviews, September 2023, Elsevier

Dr. Vicente Soriano
Current Challenges for Conscientious Objection by Physicians in Spain

Article • The Linacre Quarterly, August 2023, SAGE Publications

Dr. Vicente Soriano
Mental Health Crisis in the Youth and Rebound in Sexually Transmitted Infections

Article • Aids Reviews, August 2023, Publicidad Permanyer, SLU

Dr. Vicente Soriano
The use of �sex� and �gender� in medical research

Article • Aids Reviews, July 2023, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis

Article • International Journal of Infectious Diseases, June 2023, Elsevier

Dr. Vicente Soriano
Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study

Article • Autoimmunity Reviews, June 2023, Elsevier

Dr. Vicente Soriano
Response to: Prognostic factors in hospitalized HIV-positive patients with COVID-19: correspondence

Article • QJM, May 2023, Oxford University Press (OUP)

Dr. Vicente Soriano
The slowdown of new infections by human retroviruses has reached a plateau in Spain

Article • Journal of Medical Virology, May 2023, Wiley

Dr. Vicente Soriano
Key Safety Issues in Treating People with Both Hepatitis C and HIV

Article • Expert Opinion on Drug Safety, April 2023, Taylor & Francis

Dr. Vicente Soriano, Octavio Corral Pazos de Provens
Coinfection with Viral Hepatitis in HIV patients in 2023

Article • Aids Reviews, March 2023, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Viral hepatitis in persons living with HIV in the post-COVID era

Article • Aids Reviews, March 2023, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Genomic Determinants of Long COVID

Article • February 2023, Research Square

Dr. Vicente Soriano
Susceptibility to hepatitis B virus infection in adults living in Spain

Article • Liver International, February 2023, Wiley

Dr. Vicente Soriano, Octavio Corral Pazos de Provens
Envisioning hepatitis delta cure without functional hepatitis B cure

Article • Aids Reviews, January 2023, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy

Article • Drug Design Development and Therapy, January 2023, Taylor & Francis

Dr. Vicente Soriano
Is SARS-CoV-2 the only cause of long-COVID?

Article • Aids Reviews, December 2022, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Controversy around SARS-CoV-2 Reinfections

Article • Aids Reviews, December 2022, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Alert for polio outbreaks in developed countries

Article • Aids Reviews, November 2022, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Impact of Potent Nucleos(t)ide Therapy on Hepatitis B Hospitalizations in Spain

Article • Alimentary Pharmacology & Therapeutics, November 2022, Wiley

Dr. Vicente Soriano, Octavio Corral Pazos de Provens
Predictors of in-hospital mortality in HIV-infected patients with COVID-19

Article • QJM, September 2022, Oxford University Press (OUP)

Dr. Vicente Soriano
Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies

Article • International Journal of Infectious Diseases, September 2022, Elsevier

Dr. Vicente Soriano
Pre-Exposure Prophylaxis for viral infections other than HIV

Article • Infezioni in Medicina, September 2022, Edizioni Internazionali srl, Divisione EDIMES Edizioni Medico-Scientifiche

Dr. Vicente Soriano
The unexpected high prevalence of HBV subgenotype D4 in patients with chronic hepatitis B in Galicia, a northwestern Spanish region, reflects strong links with Latin America

Article • Journal of Clinical Virology, August 2022, Elsevier

Dr. Vicente Soriano
International outbreak of monkeypox in men having sex with men

Article • Aids Reviews, July 2022, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases

Article • Future Microbiology, July 2022, Future Medicine

Dr. Vicente Soriano
Advances in Treating Hepatitis Delta and HIV Coinfection

Article • Liver International, June 2022, Wiley

Dr. Vicente Soriano, Octavio Corral Pazos de Provens
Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies

Article • Journal of Viral Hepatitis, June 2022, Wiley

Dr. Vicente Soriano
A cure for HIV on the horizon

Article • Aids Reviews, June 2022, Publicidad Permanyer, SLU

Dr. Vicente Soriano
News from CROI 2022 - caveats using antiretrovirals as HIV prophylaxis

Article • Aids Reviews, June 2022, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain

Article • Hepatology International, June 2022, Springer Science + Business Media

Dr. Vicente Soriano
Providing Spiritual Care to In-Hospital Patients During COVID-19: A Preliminary European Fact-Finding Study

Article • Journal of Religion and Health, May 2022, Springer Science + Business Media

Dr. Vicente Soriano
Use of antibiotics in respiratory viral infections

Article • Internal and Emergency Medicine, March 2022, Springer Science + Business Media

Dr. Vicente Soriano
A greater virulent HIV-1 subtype B variant has circulated in The Netherlands since the 1990&#8217;s

Article • Aids Reviews, March 2022, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Oral antivirals for the prevention and treatment of SARS-CoV-2 infection

Article • Aids Reviews, February 2022, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Another patient has cured HIV infection

Article • Aids Reviews, January 2022, Publicidad Permanyer, SLU

Dr. Vicente Soriano
The opioid epidemic during the COVID-19 pandemic: Impact on HIV and HCV control

Article • Aids Reviews, January 2022, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Ultra-long-acting (XLA) antivirals for chronic viral hepatitis

Article • International Journal of Infectious Diseases, January 2022, Elsevier

Dr. Vicente Soriano
Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process

Article • HIV Medicine, December 2021, Wiley

Dr. Vicente Soriano
Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain

Article • International Journal of Infectious Diseases, November 2021, Elsevier

Dr. Vicente Soriano
Trends in hospitalizations and deaths in HIV-infected patients in Spain over two decades

Article • AIDS, October 2021, Wolters Kluwer Health

Dr. Vicente Soriano
New insights into the genetics of same-sex behavior

Article • Aids Reviews, October 2021, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Envisioning a hepatitis delta cure with new antivirals

Article • Future Microbiology, September 2021, Future Medicine

Dr. Vicente Soriano
Short Communication: Impact of COVID-19 on Case Reporting for HTLV and HIV-2 in Spain

Article • AIDS Research and Human Retroviruses, August 2021, Mary Ann Liebert Inc

Dr. Vicente Soriano
Hepatitis delta in patients hospitalized in Spain (1997–2018)

Article • AIDS, July 2021, Wolters Kluwer Health

Dr. Vicente Soriano
COVID-19 in Madrid: Leading Pandemic Control after being the Spanish Epicenter

Article • Aids Reviews, June 2021, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Consideraciones sobre la infección por HTLV-1 en España

Article • Medicina Clínica, June 2021, Elsevier

Dr. Vicente Soriano
Third wave of COVID-19 in Madrid, Spain

Article • International Journal of Infectious Diseases, June 2021, Elsevier

Dr. Vicente Soriano
The time to offer treatments for COVID-19

Article • Expert Opinion on Investigational Drugs, April 2021, Taylor & Francis

Dr. Vicente Soriano
Main differences between the first and second waves of COVID-19 in Madrid, Spain

Article • International Journal of Infectious Diseases, April 2021, Elsevier

Dr. Vicente Soriano
Antiretroviral Therapy for HIV-2 Infection in Non-Endemic Regions

Article • Aids Reviews, March 2021, Publicidad Permanyer, SLU

Dr. Vicente Soriano
COVID-19 Comes 40 Years After AIDS - Any Lesson?

Article • Aids Reviews, March 2021, Publicidad Permanyer, SLU

Dr. Vicente Soriano
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials

Article • Aids Reviews, March 2021, Publicidad Permanyer, SLU

Dr. Vicente Soriano
New SARS-CoV-2 Variants Challenge Vaccines Protection

Article • Aids Reviews, March 2021, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Clinical Outcome in Human T-Lymphotropic Virus Type 2 Carriers Following Organ Transplantation

Article • Transplantation Proceedings, March 2021, Elsevier

Dr. Vicente Soriano
Situación epidemiológica actual de la infección por VIH-2 y HTLV-1 en España

Article • Medicina Clínica, March 2021, Elsevier

Dr. Vicente Soriano
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis

Article • Clinical Infectious Diseases, February 2021, Oxford University Press (OUP)

Dr. Vicente Soriano
Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach

Article • Journal of the International Association of Providers of AIDS Care (JIAPAC), January 2021, SAGE Publications

Dr. Vicente Soriano
Unveiling Long COVID-19 Disease

Article • Aids Reviews, December 2020, Publicidad Permanyer, SLU

Dr. Vicente Soriano
A Key Action Plan for EDUCATION in a Global Crisis

Article • December 2020, Springer Science + Business Media

Dr. Vicente Soriano
Acute Viral Hepatitis in Men Having Sex with Men

Article • Aids Reviews, October 2020, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Coronavirus and other airborne agents with pandemic potential

Article • Current Opinion in Environmental Science & Health, October 2020, Elsevier

Dr. Vicente Soriano
Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity

Article • International Journal of Infectious Diseases, August 2020, Elsevier

Dr. Vicente Soriano
Long-acting antiretroviral therapy

Article • Nature Materials, July 2020, Springer Science + Business Media

Dr. Vicente Soriano
The Resurgence of Medical Ethics During the Coronavirus Disease (COVID)-19 Outbreak

Article • Aids Reviews, July 2020, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Very Long-acting Antivirals as Chemovaccines for Preventing Viral Infections

Article • Aids Reviews, July 2020, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Adults in Madrid, Spain

Article • Clinical Infectious Diseases, June 2020, Oxford University Press (OUP)

Dr. Vicente Soriano
THE TIME COURSE OF THERAPEUTIC INTERVENTIONS FOR COVID-19

Article • June 2020, Cold Spring Harbor Laboratory Press

Dr. Vicente Soriano
Hospital admissions in individuals with HTLV-1 infection in Spain

Article • AIDS, June 2020, Wolters Kluwer Health

Dr. Vicente Soriano
Poetry in Response to the “Disengagement Plan”: Identity, Poetics and Politics

Article • CLCWeb Comparative Literature and Culture, April 2020, Purdue University (bepress)

Dr. Vicente Soriano
HTLV-1 infection and health outcomes

Article • The Lancet Infectious Diseases, April 2020, Elsevier

Dr. Vicente Soriano
HTLV-1 infection and health outcomes

Article • The Lancet Infectious Diseases, April 2020, Elsevier

Dr. Vicente Soriano
Tough requirements for new antiretroviral drugs

Article • The Lancet HIV, March 2020, Elsevier

Dr. Vicente Soriano
Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2

Article • The Journal of Infectious Diseases, January 2020, Oxford University Press (OUP)

Dr. Vicente Soriano
Advances in hepatitis B therapeutics

Article • Therapeutic Advances in Infectious Disease, January 2020, SAGE Publications

Dr. Vicente Soriano
Keeping alive enterprises while embracing unprecedented COVID-19 restrictions

Article • Therapeutic Advances in Infectious Disease, January 2020, SAGE Publications

Dr. Vicente Soriano
Multiple recombinant events in human T-cell Leukemia virus Type 1: complete sequences of recombinant African strains

Article • Emerging Microbes & Infections, January 2020, Taylor & Francis

Dr. Vicente Soriano
Overt and occult hepatitis B among immigrants and native blood donors in Madrid, Spain

Article • Therapeutic Advances in Infectious Disease, January 2020, SAGE Publications

Dr. Vicente Soriano
Why such excess of mortality for COVID-19 in Spain?

Article • Therapeutic Advances in Infectious Disease, January 2020, SAGE Publications

Dr. Vicente Soriano
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT...

Article • Journal of Antimicrobial Chemotherapy, November 2019, Oxford University Press (OUP)

Dr. Vicente Soriano
Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain

Article • AIDS, November 2019, Wolters Kluwer Health

Dr. Vicente Soriano
HTLV testing of solid organ transplant donors

Article • Clinical Transplantation, October 2019, Wiley

Dr. Vicente Soriano
HTLV-1 infection in solid organ transplant donors and recipients in Spain

Article • BMC Infectious Diseases, August 2019, Springer Science + Business Media

Dr. Vicente Soriano
Update of the statements on biology and clinical impact of occult hepatitis B virus infection

Article • Journal of Hepatology, August 2019, Elsevier

Dr. Vicente Soriano
A18 HIV-2 molecular epidemiology in Spain: 30 years since the first case

Article • Virus Evolution, August 2019, Oxford University Press (OUP)

Dr. Vicente Soriano
Jérôme Lejeune passed away 25 years ago

Article • Hereditas, June 2019, Springer Science + Business Media

Dr. Vicente Soriano
HIV co-infection in HTLV-1 carriers in Spain

Article • Virus Research, June 2019, Elsevier

Dr. Vicente Soriano
Hepatitis Delta Estimates in the United States Revisited

Article • Clinical Infectious Diseases, April 2019, Oxford University Press (OUP)

Dr. Vicente Soriano
Occult hepatitis B and HIV infection

Article • European Journal of Gastroenterology & Hepatology, April 2019, Wolters Kluwer Health

Dr. Vicente Soriano
Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

Article • Journal of Antimicrobial Chemotherapy, February 2019, Oxford University Press (OUP)

Dr. Vicente Soriano
Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus

Article • Open Forum Infectious Diseases, February 2019, Oxford University Press (OUP)

Dr. Vicente Soriano
Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain

Article • Open Forum Infectious Diseases, January 2019, Oxford University Press (OUP)

Dr. Vicente Soriano
Rebound in Sexually Transmitted Infections Following the Success of Antiretrovirals for HIV/AIDS

Article • Aids Reviews, January 2019, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Screening for retroviruses and hepatitis viruses using dried blood spots reveals a high prevalence of occult hepatitis B in Ghana

Article • Therapeutic Advances in Infectious Disease, January 2019, SAGE Publications

Dr. Vicente Soriano
Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals

Article • Therapeutic Advances in Infectious Disease, January 2019, SAGE Publications

Dr. Vicente Soriano
Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results From NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine or Raltegravir

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2018, Wolters Kluwer Health

Dr. Vicente Soriano
Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain

Article • European Journal of Gastroenterology & Hepatology, September 2018, Wolters Kluwer Health

Dr. Vicente Soriano
Short article

Article • European Journal of Gastroenterology & Hepatology, September 2018, Wolters Kluwer Health

Dr. Vicente Soriano
Flash Smelting Copper Concentrates Spectral Emission Measurements

Article • Sensors, June 2018, MDPI AG

Dr. Vicente Soriano
AIDS Clinical Research in Spain—Large HIV Population, Geniality of Doctors, and Missing Opportunities

Article • Viruses, May 2018, MDPI AG

Dr. Vicente Soriano
Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

Article • Clinical Infectious Diseases, May 2018, Oxford University Press (OUP)

Dr. Vicente Soriano
Report from the International Conference on Viral Hepatitis (ICVH) – Chicago, October 2017

Article • Aids Reviews, April 2018, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Treatment and prevention of HIV infection with long-acting antiretrovirals

Article • Expert Review of Clinical Pharmacology, March 2018, Taylor & Francis

Dr. Vicente Soriano
Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges

Article • Cancer, February 2018, Wiley

Dr. Vicente Soriano
Hepatitis Delta Enters a New Therapeutic Era

Article • The Journal of Infectious Diseases, February 2018, Oxford University Press (OUP)

Dr. Vicente Soriano
Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

Article • Open Forum Infectious Diseases, October 2017, Oxford University Press (OUP)

Dr. Vicente Soriano
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure

Article • Aids Reviews, October 2017, Publicidad Permanyer, SLU

Dr. Vicente Soriano
Human T-Lymphotropic Virus Infection in Hepatitis C Virus–Antibody Positive Patients in Spain

Article • AIDS Research and Human Retroviruses, October 2017, Mary Ann Liebert Inc

Dr. Vicente Soriano
Need to Face Liver Cirrhosis after HCV Cure with Antivirals

Article • EBioMedicine, October 2017, Elsevier

Dr. Vicente Soriano
Is Ribavirin Teratogenic in Humans? No Evidence So Far

Article • Drug Safety, September 2017, Springer Science + Business Media

Dr. Vicente Soriano
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

Article • PLoS ONE, September 2017, PLOS

Dr. Vicente Soriano
Antiretroviral treatment of HIV-2 infection

Article • Future Virology, August 2017, Future Medicine

vicente soriano, Dr. Vicente Soriano
Treatment of hepatitis C with new fixed dose combinations

Article • Expert Opinion on Pharmacotherapy, July 2017, Taylor & Francis

Dr. Vicente Soriano
Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C

Article • Expert Opinion on Drug Metabolism & Toxicology, July 2017, Taylor & Francis

Dr. Vicente Soriano
CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study

Article • Journal of Antimicrobial Chemotherapy, July 2017, Oxford University Press (OUP)

Dr. Vicente Soriano
Drug interactions in HIV-infected patients treated for hepatitis C

Article • Expert Opinion on Drug Metabolism & Toxicology, July 2017, Taylor & Francis

Dr. Vicente Soriano
Dual antiretroviral therapy for HIV infection

Article • Expert Opinion on Drug Safety, July 2017, Taylor & Francis

Dr. Vicente Soriano
Human T-lymphotropic virus type 1 infection and disease in Spain

Article • AIDS, July 2017, Wolters Kluwer Health

Dr. Vicente Soriano
HIV type 2 epidemic in Spain

Article • AIDS, June 2017, Wolters Kluwer Health

Dr. Vicente Soriano
New antivirals for the treatment of chronic hepatitis B

Article • Expert Opinion on Investigational Drugs, May 2017, Taylor & Francis

Dr. Vicente Soriano
Characterization of Free Phenytoin Concentrations in End-Stage Renal Disease Using the Winter-Tozer Equation

Article • Annals of Pharmacotherapy, May 2017, SAGE Publications

Dr. Vicente Soriano
Hepatitis delta and HIV infection

Article • AIDS, April 2017, Wolters Kluwer Health

Dr. Vicente Soriano
Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

Article • Journal of Antimicrobial Chemotherapy, March 2017, Oxford University Press (OUP)

Dr. Vicente Soriano
A loud tear — acute aortic regurgitation with an unusual presentation

Article • Kardiologia Polska, February 2017, Polskie Towarzystwo Kardiologiczne

Dr. Vicente Soriano
Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer's disease

Article • Journal of Cerebral Blood Flow & Metabolism, January 2017, SAGE Publications

Dr Pablo A Evelson, Dr. Vicente Soriano
Decline and changing profile of hepatitis delta among injection drug users in Spain

Article • Antiviral Therapy, January 2017, International Medical Press

Dr. Vicente Soriano
Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

Dr. Vicente Soriano
Impact of ITPA gene polymorphisms on the risk of ribavirin-induced haemolytic anaemia using interferon-free antivirals for chronic hepatitis C

Article • Antiviral Therapy, January 2017, International Medical Press

Dr. Vicente Soriano
The global spread of HIV-1 subtype B epidemic

Article • Infection Genetics and Evolution, December 2016, Elsevier

Dr. Vicente Soriano
Coronary angiography after successful thrombolysis — Is the recommended time interval of 24 h an important issue?

Article • International Journal of Cardiology, November 2016, Elsevier

Dr. Vicente Soriano
Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients

Article • Journal of Translational Medicine, September 2016, Springer Science + Business Media

Dr Isidoro Martinez, Dr. Vicente Soriano
Short article

Article • European Journal of Gastroenterology & Hepatology, August 2016, Wolters Kluwer Health

Dr. Vicente Soriano
Hepatitis C virus resistance to the new direct-acting antivirals

Article • Expert Opinion on Drug Metabolism & Toxicology, July 2016, Taylor & Francis

Dr. Vicente Soriano
Can evolutionary constraints explain the rarity of nitrogen‐fixing trees in high‐latitude forests?

Article • New Phytologist, July 2016, Wiley

Dr. Vicente Soriano
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

Article • JAMA, July 2016, American Medical Association (AMA)

Dr. Vicente Soriano
Is HIV still a special population for the treatment of hepatitis C?

Article • AIDS, July 2016, Wolters Kluwer Health

Dr. Vicente Soriano
A machine vision system for automatic detection of parasites Edotea magellanica in shell-off cooked clam Mulinia edulis

Article • Journal of Food Engineering, July 2016, Elsevier

Dr. Vicente Soriano
SOLAR-2: the sun also rises for cirrhotics

Article • The Lancet Infectious Diseases, June 2016, Elsevier

Dr. Vicente Soriano
Treatment patterns of adjuvant interferon-α2b for high-risk melanoma

Article • Melanoma Research, June 2016, Wolters Kluwer Health

Dr. Vicente Soriano
MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression

Article • PLoS ONE, May 2016, PLOS

Dr. Vicente Soriano
Prevention and management of treatment failure to new oral hepatitis C drugs

Article • Expert Opinion on Pharmacotherapy, May 2016, Taylor & Francis

Dr. Vicente Soriano
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004–2013

Article • Journal of Infection, May 2016, Elsevier

Dr. Vicente Soriano
Safety of vemurafenib in patients with BRAF V600 mutated metastatic melanoma: the Spanish experience

Article • Revista de Oncología, March 2016, Springer Science + Business Media

Dr. Vicente Soriano
IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection

Article • Liver International, March 2016, Wiley

Dr. Vicente Soriano
Delta hepatitis: new approaches to therapy

Article • Future Virology, March 2016, Future Medicine

Dr. Vicente Soriano
Short Communication: CXCL12 rs1029153 Polymorphism Is Associated with the Sustained Virological Response in HIV/Hepatitis C Virus-Coinfected Patients on Hepatitis C Virus Therapy

Article • AIDS Research and Human Retroviruses, March 2016, Mary Ann Liebert Inc

Dr. Vicente Soriano
Infection-related and -unrelated malignancies, HIV and the aging population

Article • HIV Medicine, February 2016, Wiley

Dr. Vicente Soriano
Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials

Article • Antiviral Therapy, January 2016, International Medical Press

Dr. Vicente Soriano
High serum HCV RNA in chronic hepatitis C patients coinfected with HIV despite successful antiretroviral therapy

Article • Antiviral Therapy, January 2016, International Medical Press

Dr. Vicente Soriano
HUMAN T-LYMPHOTROPIC VIRUS 1 (HTLV-1) AND HUMAN T-LYMPHOTROPIC VIRUS 2 (HTLV-2): GEOGRAPHICAL RESEARCH TRENDS AND COLLABORATION NETWORKS (1989-2012)

Article • Revista do Instituto de Medicina Tropical de São Paulo, January 2016, FapUNIFESP (SciELO)

Dr. Vicente Soriano
Rapid Changes in Cholesterol in Chronic Hepatitis C Patients Treated with Antivirals and Potential Impacton Cardiovascular Risk

Article • Journal of Hepatology, January 2016, Elsevier

Dr. Vicente Soriano
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART

Article • Journal of Antimicrobial Chemotherapy, December 2015, Oxford University Press (OUP)

Professor Peter Sasieni, Dr. Vicente Soriano
ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection

Article • PLoS ONE, December 2015, PLOS

Dr. Vicente Soriano
Epigenetic regulation of puberty via Zinc finger protein-mediated transcriptional repression

Article • Nature Communications, December 2015, Springer Science + Business Media

Dr. Vicente Soriano
Immunoregulatory Role of Myeloid-derived Cells in Inflammatory Bowel Disease

Article • Inflammatory Bowel Diseases, December 2015, Oxford University Press (OUP)

Dr. Vicente Soriano
Linfoma primário do coração em doente com neoplasia renal síncrona

Article • Revista Portuguesa de Cardiologia, December 2015, Elsevier

Dr. Vicente Soriano
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy

Article • HIV Medicine, November 2015, Wiley

Dr. Vicente Soriano, Professor Peter Sasieni
Hypoglycemia in a diabetic patient during hepatitis C therapy

Article • Hepatology, November 2015, Wiley

Dr. Vicente Soriano
New hepatitis C therapies for special patient populations

Article • Expert Opinion on Pharmacotherapy, November 2015, Informa Healthcare

Dr. Vicente Soriano
Corrigendum

Article • HIV Clinical Trials, November 2015, Taylor & Francis

Dr. Vicente Soriano
Bone mineral density and inflammatory and bone biomarkers after darunavir–ritonavir combined with either raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

Article • The Lancet HIV, November 2015, Elsevier

Dr. Vicente Soriano
Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe

Article • Clinical Microbiology and Infection, November 2015, Elsevier

Dr. Vicente Soriano
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

Article • PLoS ONE, October 2015, PLOS

Dr Alejandro J Krolewiecki, Dr. Vicente Soriano, Dr Graham A Williams
Rate and predictors of serum HCV-RNA >6 million IU/mL in patients with chronic hepatitis C

Article • Journal of Clinical Virology, October 2015, Elsevier

Dr. Vicente Soriano
Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

Article • Hepatology, October 2015, Wiley

Dr. Vicente Soriano
Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients

Article • Journal of Viral Hepatitis, September 2015, Wiley

Dr. Vicente Soriano
IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection

Article • AIDS, September 2015, Wolters Kluwer Health

Dr. Vicente Soriano
Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients

Article • Current Opinion in HIV and AIDS, September 2015, Wolters Kluwer Health

Dr. Vicente Soriano
Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma

Article • European Journal of Cancer, September 2015, Elsevier

Dr. Vicente Soriano
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study

Article • The Lancet HIV, August 2015, Elsevier

Dr. Vicente Soriano
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study

Article • HIV Medicine, July 2015, Wiley

Dr. Vicente Soriano, Prof Robert Colebunders
Tenofovir for Hepatitis Delta

Article • Hepatology, July 2015, Wiley

Dr. Vicente Soriano
Dual antiviral therapy for HIV and hepatitis C – drug interactions and side effects

Article • Expert Opinion on Drug Safety, July 2015, Informa Healthcare

Dr. Vicente Soriano
Emerging Challenges in Managing Hepatitis B in HIV Patients

Article • Current HIV/AIDS Reports, July 2015, Springer Science + Business Media

Dr. Vicente Soriano
Clinical Translation of Nanomedicine

Article • Chemical Reviews, June 2015, American Chemical Society (ACS)

Dr. Vicente Soriano
Acute hepatitis C virus re-infection in a heterosexual HIV-positive partner

Article • Liver International, June 2015, Wiley

Dr. Vicente Soriano
From respiratory sensitization to food allergy: Anaphylactic reaction after ingestion of mushrooms (Agaricus bisporus)

Article • Medical Mycology Case Reports, June 2015, Elsevier

Dr. Vicente Soriano
Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis

Article • PLoS Medicine, June 2015, PLOS

Dr. Vicente Soriano
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study

Article • HIV Medicine, May 2015, Wiley

Dr. Vicente Soriano
Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?

Article • Liver International, April 2015, Wiley

Dr. Vicente Soriano
High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes

Article • Journal of Epidemiology & Community Health, April 2015, BMJ

Dr. Vicente Soriano
High nevus counts confer a favorable prognosis in melanoma patients

Article • International Journal of Cancer, April 2015, Wiley

Dr. Vicente Soriano
Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis

Article • PLoS Medicine, April 2015, PLOS

Dr. Vicente Soriano
Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor–Based Combination Antiretroviral Therapy

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2015, Wolters Kluwer Health

Dr. Vicente Soriano, Prof Robert Colebunders
Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents

Article • HIV Clinical Trials, April 2015, Taylor & Francis

Dr. Vicente Soriano
TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients

Article • Journal of Clinical Virology, April 2015, Elsevier

Dr. Vicente Soriano
P0838 : Progression to advanced liver fibrosis in HIV/HCV-coinfected patients and prioritization of new hepatitis C therapies

Article • Journal of Hepatology, April 2015, Elsevier

Dr. Vicente Soriano
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

Article • PLoS Medicine, March 2015, PLOS

Dr Alejandro J Krolewiecki, Dr. Vicente Soriano, Lut Lynen, Hugh Montgomery, Prof Robert Colebunders
Dolutegravir for the treatment of HIV-2 infection

Article • Journal of Clinical Virology, March 2015, Elsevier

Dr. Vicente Soriano
Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs

Article • Virology Journal, January 2015, Springer Science + Business Media

Dr. Vicente Soriano
Gastrointestinal: Botulinum toxin effective in refractory gastroparesis in paediatric practice

Article • Journal of Gastroenterology and Hepatology, January 2015, Wiley

Dr. Vicente Soriano
Agonist-Dependent Modulation of Cell Surface Expression of the Cold Receptor TRPM8

Article • Journal of Neuroscience, January 2015, Society for Neuroscience

Professor Katharina Zimmermann, Dr. Vicente Soriano
Boosted Lopinavir– Versus Boosted Atazanavir–Containing Regimens and Immunologic, Virologic, and Clinical Outcomes: A Prospective Study of HIV-Infected Individuals in High-Income Countries

Article • Clinical Infectious Diseases, January 2015, Oxford University Press (OUP)

Dr. Vicente Soriano
Drug interactions with new hepatitis C oral drugs

Article • Expert Opinion on Drug Metabolism & Toxicology, January 2015, Informa Healthcare

Dr. Vicente Soriano
Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis

Article • Antiviral Therapy, January 2015, International Medical Press

Dr. Vicente Soriano
Hepatitis C cure with antiviral therapy – benefits beyond the liver

Article • Antiviral Therapy, January 2015, International Medical Press

Dr. Vicente Soriano
Shorter Telomere Length Predicts Poorer Immunological Recovery in Virologically Suppressed HIV-1–Infected Patients Treated With Combined Antiretroviral Therapy

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2015, Wolters Kluwer Health

Dr. Vicente Soriano
STARTVerso4

Article • AIDS, January 2015, Wolters Kluwer Health

Dr. Vicente Soriano
Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults

Article • Clinical Microbiology and Infection, January 2015, Elsevier

Dr. Vicente Soriano
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007–2012)

Article • Clinical Microbiology and Infection, January 2015, Elsevier

Dr. Vicente Soriano
Integrase Inhibitors

Article • January 2015, Springer Science + Business Media

Dr. Vicente Soriano
Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions

Article • PLoS ONE, December 2014, PLOS

Dr. Vicente Soriano
Advances in treating drug-resistant hepatitis B virus in HIV-infected patients

Article • Expert Opinion on Pharmacotherapy, December 2014, Informa Healthcare

Dr. Vicente Soriano
Efficacy and Safety of Faldaprevir, Deleobuvir, and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C Virus Infection and Advanced Liver Fibrosis or Cirrhosis

Article • Antimicrobial Agents and Chemotherapy, December 2014, ASM Journals

Dr. Vicente Soriano
Ipilimumab for advanced melanoma

Article • Melanoma Research, December 2014, Wolters Kluwer Health

Dr. Vicente Soriano
Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease

Article • AIDS, November 2014, Wolters Kluwer Health

Dr. Vicente Soriano
Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

Article • The Lancet, November 2014, Elsevier

Dr. Vicente Soriano
Redefining the HIV epidemic in Nigeria

Article • AIDS, November 2014, Wolters Kluwer Health

Dr. Vicente Soriano
Gene therapy for HIV infection

Article • Expert Opinion on Biological Therapy, October 2014, Informa Healthcare

Dr. Vicente Soriano
Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study

Article • Liver International, October 2014, Wiley

Dr Stuart C. Ray, Dr. Vicente Soriano
Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients

Article • AIDS, October 2014, Wolters Kluwer Health

Dr. Vicente Soriano
PPARγ2 Pro12Ala Polymorphism Is Associated With Sustained Virological Response in HIV/HCV-Coinfected Patients Under HCV Therapy

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2014, Wolters Kluwer Health

Dr. Vicente Soriano
Molecular Epidemiology and Clinical Features of Human T Cell Lymphotropic Virus Type 1 Infection in Spain

Article • AIDS Research and Human Retroviruses, September 2014, Mary Ann Liebert Inc

Dr. Vicente Soriano
Braf Mutation Analysis in Cell Free Tumoral Dna (Cfdna) of Melanoma Patients: Preliminary Results from the Spanish Melanoma Group Prospective Study Gem1304

Article • Annals of Oncology, September 2014, Elsevier

Dr. Vicente Soriano
Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies

Article • PLoS ONE, July 2014, PLOS

Dr. Vicente Soriano
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

Article • The Lancet, July 2014, Elsevier

Dr. Vicente Soriano, Prof Robert Colebunders
Hepatitis E: una enfermedad viral emergente

Article • Medicina Clínica, July 2014, Elsevier

Dr. Vicente Soriano
X4 tropic viruses are on the rise in recent HIV-1 seroconverters in Spain

Article • AIDS, July 2014, Wolters Kluwer Health

Dr. Vicente Soriano
Pharmacogenetics of antiretroviral therapy

Article • Expert Opinion on Drug Metabolism & Toxicology, June 2014, Informa Healthcare

Dr. Vicente Soriano
A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe

Article • Infection, June 2014, Springer Science + Business Media

Dr. Vicente Soriano, Prof Robert Colebunders
Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy

Article • AIDS, June 2014, Wolters Kluwer Health

Dr. Vicente Soriano
Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes

Article • The International Journal of Tuberculosis and Lung Disease, June 2014, International Union Against Tuberculosis and Lung Disease

Dr. Vicente Soriano
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

Article • HIV Medicine, May 2014, Wiley

Dr. Vicente Soriano, Prof Robert Colebunders
High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance

Article • HIV Medicine, May 2014, Wiley

Dr. Vicente Soriano
Treatment of hepatitis C in HIV patients in the new DAA era

Article • BMC Infectious Diseases, May 2014, Springer Science + Business Media

Dr. Vicente Soriano
Towards hepatitis C eradication from the HIV-infected population

Article • Antiviral Research, May 2014, Elsevier

Dr. Vicente Soriano
HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

Article • Journal of Antimicrobial Chemotherapy, April 2014, Oxford University Press (OUP)

Enrique J. Calderon, Dr. Vicente Soriano
Dolutegravir, abacavir and lamivudine as HIV therapy

Article • Expert Opinion on Pharmacotherapy, April 2014, Informa Healthcare

Dr. Vicente Soriano
IFNL4 ss469415590 Variant Shows Similar Performance to rs12979860 as Predictor of Response to Treatment against Hepatitis C Virus Genotype 1 or 4 in Caucasians

Article • PLoS ONE, April 2014, PLOS

Dr. Vicente Soriano
Management and treatment of chronic hepatitis B in HIV-positive patients

Article • Annals of Medicine, April 2014, Taylor & Francis

Dr. Vicente Soriano
Infecciones por el virus de la inmunodeficiencia humana tipo 2 y por los virus linfotrópicos de células T humanas en España

Article • Medicina Clínica, April 2014, Elsevier

Dr. Vicente Soriano
Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy

Article • Journal of Infection, April 2014, Elsevier

Dr. Vicente Soriano
P751 DISTINCT VALUES OF LIVER STIFFNESS PREDICT PROGRESSION TO ADVANCED LIVER FIBROSIS IN HIV-INFECTED PATIENTS WITH CHRONIC HEPATITIS C

Article • Journal of Hepatology, April 2014, Elsevier

Dr. Vicente Soriano
P1068 EFFICACY OF PROLONGED TENOFOVIR THERAPY ON HEPATITIS DELTA IN HIV-INFECTED PATIENTS

Article • Journal of Hepatology, April 2014, Elsevier

Dr. Vicente Soriano
P755 HEPATITIS C COINFECTION INDEPENDENTLY INCREASES CARDIOVASCULAR RISK IN HIV-INFECTED PATIENTS

Article • Journal of Hepatology, April 2014, Elsevier

Dr. Vicente Soriano
P1133 COMPARISON OF 24 AND 48 WEEKS OF TREATMENT WITH FALDAPREVIR AND PEGYLATED INTERFERON/RIBAVIRIN IN PATIENTS WITH DETECTABLE BUT NOT QUANTIFIABLE HCV RNA AT WEEK 4

Article • Journal of Hepatology, April 2014, Elsevier

Dr. Vicente Soriano
P1157 IMPACT OF BASELINE VARIABLES ON RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN PATIENTS WITH HIV/HCV GENOTYPE-1 COINFECTION IN A PHASE III TRIAL

Article • Journal of Hepatology, April 2014, Elsevier

Dr. Vicente Soriano
P750 SPONTANEOUS HCV CLEARANCE IN HIV PATIENTS WITH CHRONIC HEPATITIS C BEARING FAVORABLE IL28B ALLELES ON ANTIRETROVIRAL THERAPY

Article • Journal of Hepatology, April 2014, Elsevier

Dr. Vicente Soriano
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study

Article • BMC Nephrology, March 2014, Springer Science + Business Media

Dr. Vicente Soriano, Prof Robert Colebunders
Clinically Relevant Transmitted Drug Resistance to First Line Antiretroviral Drugs and Implications for Recommendations

Article • PLoS ONE, March 2014, PLOS

Dr. Vicente Soriano
Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients

Article • Clinical Infectious Diseases, March 2014, Oxford University Press (OUP)

Dr. Vicente Soriano
Deteriorating renal function and clinical outcomes in HIV-positive persons

Article • AIDS, March 2014, Wolters Kluwer Health

Dr. Vicente Soriano, Prof Robert Colebunders
European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV-coinfected patients

Article • HIV Medicine, February 2014, Wiley

Dr. Vicente Soriano
Prognostic Value of Vitamin D Level for All-cause Mortality, and Association With Inflammatory Markers, in HIV-infected Persons

Article • The Journal of Infectious Diseases, February 2014, Oxford University Press (OUP)

Dr. Vicente Soriano
Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection

Article • Virology, February 2014, Elsevier

Dr. Vicente Soriano
Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis

Article • AIDS, February 2014, Wolters Kluwer Health

Dr. Vicente Soriano
Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction

Article • Open Heart, February 2014, BMJ

Dr. Vicente Soriano
Immuno-Virological Discordance and the Risk of Non-AIDS and AIDS Events in a Large Observational Cohort of HIV-Patients in Europe

Article • PLoS ONE, January 2014, PLOS

Dr. Vicente Soriano, Prof Robert Colebunders
Progression to advanced liver fibrosis in HIV/HCV-coinfected patients and prioritization of new hepatitis C therapies

Article • Antiviral Therapy, January 2014, International Medical Press

Dr. Vicente Soriano
Liver fibrosis progression despite HCV cure with antiviral therapy in HIV–HCV-coinfected patients

Article • Antiviral Therapy, January 2014, International Medical Press

Dr. Vicente Soriano
Long-term survival and liver-related events after peginterferon/ribavirin therapy in HIV-infected patients with chronic hepatitis C

Article • Antiviral Therapy, January 2014, International Medical Press

Dr. Vicente Soriano
Very late HCV relapse following triple therapy for hepatitis C

Article • Antiviral Therapy, January 2014, International Medical Press

Dr. Vicente Soriano
ACSM4 Polymorphisms Are Associated With Rapid AIDS Progression in HIV-Infected Patients

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2014, Wolters Kluwer Health

Dr. Vicente Soriano
A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington’s disease in mice

Article • Nature Communications, December 2013, Springer Science + Business Media

Dr. Vicente Soriano
Emerging antiretroviral drugs

Article • Expert Opinion on Pharmacotherapy, November 2013, Informa Healthcare

Dr. Vicente Soriano
Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs

Article • HIV Medicine, November 2013, Wiley

Dr Victor Asensi, Dr. Vicente Soriano
Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2013, New England Journal of Medicine (NEJM/MMS)

Dr. Vicente Soriano
Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection

Article • AIDS, November 2013, Wolters Kluwer Health

Dr. Vicente Soriano
Associations between immune depression and cardiovascular events in HIV infection

Article • AIDS, November 2013, Wolters Kluwer Health

Dr. Vicente Soriano
Strategic use of lamivudine in the management of chronic hepatitis B

Article • Antiviral Research, November 2013, Elsevier

Dr. Vicente Soriano
A polymorphism linked to RRAS ,SCAF1 ,IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers

Article • Liver International, October 2013, Wiley

Dr. Vicente Soriano
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study

Article • BMC Infectious Diseases, October 2013, Springer Science + Business Media

Dr Maria Rosaria Capobianchi, Dr. Vicente Soriano
Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy

Article • Journal of Viral Hepatitis, October 2013, Wiley

Dr. Vicente Soriano
Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy

Article • Journal of Clinical Virology, October 2013, Elsevier

Dr. Vicente Soriano
Epidemiology of viral hepatitis

Article • Hepatology, October 2013, Wiley

Dr. Vicente Soriano
Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: a study in a Spanish cohort

Article • HIV Medicine, September 2013, Wiley

Dr. Vicente Soriano
Treating hepatitis C in injection drug users

Article • Nature Reviews Gastroenterology & Hepatology, September 2013, Springer Science + Business Media

Dr. Vicente Soriano
Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B

Article • AIDS, September 2013, Wolters Kluwer Health

Dr. Vicente Soriano
Treatment of Hepatitis C in HIV Patients in the New Era of Direct-Acting Antivirals

Article • Current Hepatology Reports, August 2013, Springer Science + Business Media

Dr. Vicente Soriano
Phase I–II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma

Article • British Journal of Cancer, August 2013, Springer Science + Business Media

Dr. Vicente Soriano
All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997–2010

Article • BMC Infectious Diseases, August 2013, Springer Science + Business Media

Dr. Vicente Soriano
Faldaprevir and Deleobuvir for HCV Genotype 1 Infection

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2013, New England Journal of Medicine (NEJM/MMS)

Dr. Vicente Soriano
Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Article • Journal of Hepatology, August 2013, Elsevier

Dr. Vicente Soriano
Recortes sanitarios e infección por el virus de la inmunodeficiencia humana

Article • Medicina Clínica, August 2013, Elsevier

Dr. Vicente Soriano
Hepatitis B in HIV-Infected Patients

Article • Clinics in Liver Disease, August 2013, Elsevier

Dr. Vicente Soriano
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

Article • HIV Medicine, July 2013, Wiley

Dr. Vicente Soriano
Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves

Article • Journal of Medical Virology, July 2013, Wiley

Dr. Vicente Soriano
Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1

Article • Deutsche Zeitschrift für Nervenheilkunde, July 2013, Springer Science + Business Media

Dr. Vicente Soriano
Update on HIV/HCV Coinfection

Article • Current HIV/AIDS Reports, July 2013, Springer Science + Business Media

Dr. Vicente Soriano
Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia

Article • Journal of Antimicrobial Chemotherapy, July 2013, Oxford University Press (OUP)

Dr. Vicente Soriano
Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response

Article • Journal of Infection, July 2013, Elsevier

Dr. Vicente Soriano
Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients

Article • AIDS, July 2013, Wolters Kluwer Health

Dr. Vicente Soriano
Antiretroviral drug-related toxicities – clinical spectrum, prevention, and management

Article • Expert Opinion on Drug Safety, June 2013, Informa Healthcare

Dr. Vicente Soriano
Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

Article • Liver International, June 2013, Wiley

Dr. Vicente Soriano
HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein

Article • AIDS, June 2013, Wolters Kluwer Health

Dr. Vicente Soriano
Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection

Article • European Journal of Clinical Microbiology & Infectious Diseases, May 2013, Springer Science + Business Media

Dr. Vicente Soriano
Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients

Article • PLoS ONE, May 2013, PLOS

Dr. Vicente Soriano
Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV

Article • Annals of Internal Medicine, May 2013, American College of Physicians

Dr. Vicente Soriano
Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus

Article • Journal of Virology, May 2013, ASM Journals

Professor Elodie Ghedin, Dr. Vicente Soriano
Unusual manifestations of a common gastrointestinal disorder

Article • Journal of Paediatrics and Child Health, May 2013, Wiley

Dr. Vicente Soriano
HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy

Article • AIDS, May 2013, Wolters Kluwer Health

Dr. Vicente Soriano
Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes

Article • Journal of Antimicrobial Chemotherapy, April 2013, Oxford University Press (OUP)

Dr. Vicente Soriano
Hepatitis C therapy with HCV NS5B polymerase inhibitors

Article • Expert Opinion on Pharmacotherapy, April 2013, Informa Healthcare

Dr. Vicente Soriano
Chronic Hepatitis E in HIV Patients: Rapid Progression to Cirrhosis and Response to Oral Ribavirin

Article • Clinical Infectious Diseases, April 2013, Oxford University Press (OUP)

Dr. Vicente Soriano
Hepatitis B, C, and D and HIV Infections among Immigrants from Equatorial Guinea Living in Spain

Article • American Journal of Tropical Medicine and Hygiene, April 2013, American Society of Tropical Medicine and Hygiene

Dr. Vicente Soriano
Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy

Article • AIDS, April 2013, Wolters Kluwer Health

Dr. Vicente Soriano
Low risk of liver toxicity using the most recently approved antiretroviral agents but still increased in HIV–hepatitis C virus coinfected patients

Article • AIDS, April 2013, Wolters Kluwer Health

Dr. Vicente Soriano
985 INCREASING RATES OF ACUTE HEPATITIS C ALONG WITH HIGH RATES OF SYPHILIS IN HIV-POSITIVE MEN WHO HAVE SEX WITH MEN IN MADRID

Article • Journal of Hepatology, April 2013, Elsevier

Dr. Vicente Soriano
1227 AN ANALYSIS OF RESPONSE RATES BY FIBROSIS STAGE IN PATIENTS TREATED WITH FALDAPREVIR, BI 207127 AND RIBAVIRIN IN THE SOUND-C2 STUDY

Article • Journal of Hepatology, April 2013, Elsevier

Dr. Vicente Soriano
496 CHANGES IN CIRCULATING HCV-RNA CONCENTRATIONS IN PATIENTS WITH CHRONIC HEPATITIS C IN THE ABSENCE OF ANTIVIRAL THERAPY

Article • Journal of Hepatology, April 2013, Elsevier

Dr. Vicente Soriano
882 GENETIC VARIATIONS IN proprotein convertase subtilisin/kexin type 9 (PCSK9) GENE ARE ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN IN HEPATITIS C VIRUS GENOTYPE 3-INFECTED PATIENTS

Article • Journal of Hepatology, April 2013, Elsevier

Dr. Vicente Soriano
1186 ITPA GENE VARIANTS PREDICT HEMOLYTIC RIBAVIRIN INDUCED ANAEMIA IN PATIENTS TREATED WITH THE INTERFERON-FREE REGIMEN OF FALDAPREVIR, BI 207127 AND RIBAVIRIN IN SOUND-C2

Article • Journal of Hepatology, April 2013, Elsevier

Dr. Vicente Soriano
883 PREDICTION OF RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN BY INTERLEUKIN 28B GENOTYPE IS MODIFIED BY SNPS AT MULTIPLE GENES IN HIV/HEPATITIS C VIRUS GENOTYPE 1/4-COINFECTED PATIENTS

Article • Journal of Hepatology, April 2013, Elsevier

Dr. Vicente Soriano
1220 TRIPLE COMBINATION THERAPY FOR HEPATITIS C WITH TELAPREVIR EXHIBITS GREATER EARLY ANTIVIRAL SUPPRESSION THAN WITH BOCEPREVIR REGARDLESS HIV STATUS

Article • Journal of Hepatology, April 2013, Elsevier

Dr. Vicente Soriano
Resistance to antiretroviral drugs

Article • April 2013, Future Medicine

Dr. Vicente Soriano
Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy

Article • HIV Medicine, March 2013, Wiley

Dr. Vicente Soriano
Transcriptional Regulation of Insulin-degrading Enzyme Modulates Mitochondrial Amyloid (A ) Peptide Catabolism and Functionality

Article • Journal of Biological Chemistry, March 2013, American Society for Biochemistry & Molecular Biology (ASBMB)

Dr Pablo A Evelson, Dr. Vicente Soriano
Contraindication of ART following a sperm FISH analysis, even though only 12% of the spermatozoa had enlarged heads

Article • Systems Biology in Reproductive Medicine, March 2013, Taylor & Francis

Dr. Vicente Soriano
Sensitive Cell-Based Assay for Determination of Human Immunodeficiency Virus Type 1 Coreceptor Tropism

Article • Journal of Clinical Microbiology, March 2013, ASM Journals

Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu, Dr. Vicente Soriano
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

Article • The Lancet, March 2013, Elsevier

Dr. Vicente Soriano
Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients

Article • AIDS, March 2013, Wolters Kluwer Health

Dr. Vicente Soriano
The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies

Article • PLoS ONE, February 2013, PLOS

Dr. Vicente Soriano
Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya

Article • The Journal of Infectious Diseases, February 2013, Oxford University Press (OUP)

Dr. Vicente Soriano
Genetic Determinants of Idiopathic Noncirrhotic Portal Hypertension in HIV-Infected Patients

Article • Clinical Infectious Diseases, January 2013, Oxford University Press (OUP)

Dr. Vicente Soriano
Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients

Article • AIDS, January 2013, Wolters Kluwer Health

Dr Mar Masiá, Dr. Vicente Soriano
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

Article • AIDS, January 2013, Wolters Kluwer Health

Dr Josep M Llibre, Dr. Vicente Soriano
Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients

Article • AIDS, January 2013, Wolters Kluwer Health

Dr. Vicente Soriano
Liver fibrosis progression in HIV–HCV-coinfected patients treated with distinct antiretroviral drugs and impact of peginterferon-ribavirin therapy

Article • Antiviral Therapy, January 2013, International Medical Press

Dr. Vicente Soriano
Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C

Article • Antiviral Therapy, January 2013, International Medical Press

Dr. Vicente Soriano
The changing face of hepatitis C in the new era of direct-acting antivirals

Article • Antiviral Research, January 2013, Elsevier

Dr. Vicente Soriano
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir

Article • Antiviral Therapy, January 2013, International Medical Press

Dr. Vicente Soriano
Insulysin

Article • January 2013, Elsevier

Dr. Vicente Soriano
Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson’s Disease?

Article • Frontiers in Cellular Neuroscience, January 2013, Frontiers

Dr. Vicente Soriano
Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library

Article • European Journal of Immunology, December 2012, Wiley

Dr. Vicente Soriano
IL28RApolymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients

Article • Journal of Viral Hepatitis, December 2012, Wiley

Dr. Vicente Soriano
A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients

Article • Journal of Antimicrobial Chemotherapy, December 2012, Oxford University Press (OUP)

Dr. Vicente Soriano
Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

Article • The Journal of Infectious Diseases, December 2012, Oxford University Press (OUP)

Dr. Vicente Soriano
Treatment of Hepatitis C in Patients Infected with Human Immunodeficiency Virus in the Direct-Acting Antiviral Era

Article • Infectious Disease Clinics of North America, December 2012, Elsevier

Dr. Vicente Soriano
HIV gag-specific immune response mediated by double negative (CD3+CD4−CD8−) T cells in HIV-exposed seronegative individuals

Article • Journal of Medical Virology, November 2012, Wiley

Dr. Vicente Soriano
Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain

Article • HIV Medicine, November 2012, Wiley

Dr. Vicente Soriano
Increases in acute hepatitis C (HCV) incidence across Europe: which regions and patient groups are affected?

Article • Journal of the International AIDS Society, November 2012, Wiley

Dr. Vicente Soriano
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

Article • Journal of the International AIDS Society, November 2012, Wiley

Dr. Vicente Soriano
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics

Article • International Journal of Epidemiology, November 2012, Oxford University Press (OUP)

Dr. Vicente Soriano
Analysis of transmitted drug resistance in Spain in the years 2007–2010 documents a decline in mutations to the non-nucleoside drug class

Article • Clinical Microbiology and Infection, November 2012, Elsevier

Dr. Vicente Soriano
KIT Mutations in a Series of Melanomas and Their Impact on Treatment With Imatinib

Article • Actas Dermo-Sifiliográficas (English Edition), November 2012, Elsevier

Dr. Vicente Soriano
Pharmacokinetics of new oral hepatitis C antiviral drugs

Article • Expert Opinion on Drug Metabolism & Toxicology, October 2012, Informa Healthcare

Dr. Vicente Soriano
Hepatitis C Therapy: Highlights From the 2012 Annual Meeting of the European Association for the Study of the Liver

Article • Clinical Infectious Diseases, October 2012, Oxford University Press (OUP)

Dr. Vicente Soriano
Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

Article • Journal of the International AIDS Society, October 2012, Wiley

Dr. Vicente Soriano
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

Article • Retrovirology, October 2012, Springer Science + Business Media

Dr Dimitrios Paraskevis, Dr. Vicente Soriano
The inaccuracy of surface-measured model-derived tibiofemoral kinematics

Article • Journal of Biomechanics, October 2012, Elsevier

Professor Scott Tashman, Dr. Vicente Soriano
Short Communication: Does Interleukin-28B Single Nucleotide Polymorphisms Influence the Natural History of Hepatitis B?

Article • AIDS Research and Human Retroviruses, October 2012, Mary Ann Liebert Inc

Dr. Vicente Soriano
Short Communication: RNASEL Alleles and Susceptibility to Infection by Human Retroviruses and Hepatitis Viruses

Article • AIDS Research and Human Retroviruses, October 2012, Mary Ann Liebert Inc

Dr. Vicente Soriano
Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms

Article • AIDS, September 2012, Wolters Kluwer Health

Dr. Vicente Soriano
Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b

Article • Journal of Clinical Virology, September 2012, Elsevier

Dr. Vicente Soriano
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients

Article • AIDS, September 2012, Wolters Kluwer Health

Dr. Vicente Soriano
Prevalence of Xenotropic Murine Leukemia Virus-Related Virus Infection in Different Risk Populations in Spain

Article • AIDS Research and Human Retroviruses, September 2012, Mary Ann Liebert Inc

Dr. Vicente Soriano
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study

Article • AIDS, August 2012, Wolters Kluwer Health

Dr. Vicente Soriano
Cardiovascular Disease Risk in HIV Infection and Endothelial Progenitor Cells

Article • The Journal of Infectious Diseases, August 2012, Oxford University Press (OUP)

Dr. Vicente Soriano
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

Article • Retrovirology, August 2012, Springer Science + Business Media

Dr. Vicente Soriano, Dr Patricia P Rodríguez-Inés
Management of hepatitis C in HIV and/or HBV co-infected patients

Article • Best Practice & Research Clinical Gastroenterology, August 2012, Elsevier

Dr. Vicente Soriano
No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients

Article • Antiviral Research, August 2012, Elsevier

Dr. Vicente Soriano
Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study

Article • PLoS ONE, July 2012, PLOS

Dr. Vicente Soriano
Comparison of High Ribavirin Induction Versus Standard Ribavirin Dosing, Plus Peginterferon- for the Treatment of Chronic Hepatitis C in HIV-Infected Patients: The PERICO Trial

Article • The Journal of Infectious Diseases, July 2012, Oxford University Press (OUP)

Dr Victor Asensi, Dr. Vicente Soriano
Short Communication High Risk of Endothelial Dysfunction in HIV Individuals May Result from Deregulation of Circulating Endothelial Cells and Endothelial Progenitor Cells

Article • AIDS Research and Human Retroviruses, July 2012, Mary Ann Liebert Inc

Dr. Vicente Soriano
Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-up

Article • AIDS, July 2012, Wolters Kluwer Health

Dr. Vicente Soriano
Cardiac Apical Aneurysm secondary to ibuprofen-induced type 1-Kounis Syndrome

Article • International Journal of Cardiology, July 2012, Elsevier

Dr. Vicente Soriano
Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms

Article • European Journal of Preventive Cardiology, June 2012, SAGE Publications

Dr. Vicente Soriano
Differences in Virological Response to Peginterferon-α Plus Ribavirin in HIV-Positive Patients Coinfected With HCV Subtypes 1a or 1b

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, June 2012, Wolters Kluwer Health

Dr. Vicente Soriano
Definition of Advanced Age in HIV-Infection: Looking for an Age Cut-Off.

Article • AIDS Research and Human Retroviruses, May 2012, Mary Ann Liebert Inc

Dr Victor Asensi, Dr. Vicente Soriano
Author's response: expert reviews: who are they for?

Article • Expert Opinion on Pharmacotherapy, May 2012, Informa Healthcare

Dr. Vicente Soriano
A New Era for Hepatitis C—New Diagnostics Tools and New Weapons

Article • ACS Medicinal Chemistry Letters, May 2012, American Chemical Society (ACS)

Dr. Vicente Soriano
HIV and Liver Disease

Article • Seminars in Liver Disease, May 2012, Thieme Publishing Group

Dr. Vicente Soriano
Infección por el VIH-2, virus linfotrópico de células T y nuevos retrovirus humanos en España

Article • Medicina Clínica, May 2012, Elsevier

Dr. Vicente Soriano
Management and Treatment of Chronic Hepatitis C in HIV Patients

Article • Seminars in Liver Disease, May 2012, Thieme Publishing Group

Dr. Vicente Soriano
Collapsin response mediator protein-2 phosphorylation promotes the reversible retraction of oligodendrocyte processes in response to non-lethal oxidative stress

Article • Journal of Neurochemistry, April 2012, Wiley

Dr. Vicente Soriano
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials

Article • Journal of Antimicrobial Chemotherapy, April 2012, Oxford University Press (OUP)

Dr Alejandro J Krolewiecki, Dr. Vicente Soriano
Rilpivirine: a next-generation non-nucleoside analogue for the treatment of HIV infection

Article • Expert Opinion on Pharmacotherapy, April 2012, Informa Healthcare

Dr. Vicente Soriano
B3 Identification of Neutralizing Antibodies and Their Epitopes From HIV Controllers

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2012, Wolters Kluwer Health

Dr. Vicente Soriano
Intrapatient and Interpatient Pharmacokinetic Variability of Raltegravir in the Clinical Setting

Article • Therapeutic Drug Monitoring, April 2012, Wolters Kluwer Health

Dr. Vicente Soriano
Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A

Article • Journal of General Virology, April 2012, Society for General Microbiology

Dr. Vicente Soriano
Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load

Article • Journal of Hepatology, April 2012, Elsevier

Dr. Vicente Soriano
1376 LIVER TOXICITY OF THE MOST RECENTLY APPROVED ANTIRETROVIRAL DRUGS IN HIV-INFECTED PATIENTS - OVERALL LOW RATE BUT INCREASED IN THE PRESENCE OF CHRONIC HEPATITIS C

Article • Journal of Hepatology, April 2012, Elsevier

Dr. Vicente Soriano
906 RECOGNITION OF HEPATITIS C VIRUS (HCV) MINORITY STRAINS BY COLD-PCR

Article • Journal of Hepatology, April 2012, Elsevier

Dr. Vicente Soriano
1420 THE EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF BI201335 AND BI207127 IN GENOTYPE 1 HCV PATIENTS WITH CIRRHOSIS - INTERIM ANALYSIS FROM SOUND-C2

Article • Journal of Hepatology, April 2012, Elsevier

Dr. Vicente Soriano
Impact of Antiretroviral Therapy on Tuberculosis Incidence Among HIV-Positive Patients in High-Income Countries

Article • Clinical Infectious Diseases, March 2012, Oxford University Press (OUP)

Dr. Vicente Soriano
Development of Tropical Spastic Paraparesis in Human T-Lymphotropic Virus Type 1 Carriers Is Influenced by Interleukin 28B Gene Polymorphisms

Article • Clinical Infectious Diseases, March 2012, Oxford University Press (OUP)

Dr. Vicente Soriano
Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens

Article • Antimicrobial Agents and Chemotherapy, March 2012, ASM Journals

Dr. Vicente Soriano
Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain

Article • Virology Journal, March 2012, Springer Science + Business Media

Dr. Vicente Soriano
Long-Term Use of Atazanavir in the Treament of HIV-Infected Patients

Article • Clinical Medicine Insights Therapeutics, March 2012, SAGE Publications

Dr. Vicente Soriano
Drug resistance testing in hepatitis C therapy

Article • Future Virology, March 2012, Future Medicine

Dr. Vicente Soriano
Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravir

Article • AIDS, March 2012, Wolters Kluwer Health

Dr. Vicente Soriano
Factores sociodemográficos asociados a la progresión de la infección por VIH e impacto del TARGA en una cohorte de pacientes seroconvertores en Madrid (1986-2009)

Article • Enfermedades Infecciosas y Microbiología Clínica, March 2012, Elsevier

Dr. Vicente Soriano
Plasma Raltegravir Exposure Influences the Antiviral Activity and Selection of Resistance Mutations

Article • AIDS Research and Human Retroviruses, February 2012, Mary Ann Liebert Inc

Dr. Vicente Soriano
Impact of IL28B gene polymorphisms on interferon- 3 plasma levels during pegylated interferon- /ribavirin therapy for chronic hepatitis C in patients coinfected with HIV

Article • Journal of Antimicrobial Chemotherapy, January 2012, Oxford University Press (OUP)

Dr. Vicente Soriano
Treatment failure with new hepatitis C drugs

Article • Expert Opinion on Pharmacotherapy, January 2012, Informa Healthcare

Dr. Vicente Soriano
Foreign Direct Investment vs. Foreign Portfolio Investment

Article • Management International Review, January 2012, Springer Science + Business Media

Dr. Vicente Soriano
Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization

Article • Allergy, January 2012, Wiley

Dr. Vicente Soriano
Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008–2010

Article • Antiviral Therapy, January 2012, International Medical Press

Dr. Vicente Soriano
The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression

Article • Antiviral Therapy, January 2012, International Medical Press

Dr. Vicente Soriano
Long-term exposure to combination antiretroviral therapy and risk of death from specific causes

Article • AIDS, January 2012, Wolters Kluwer Health

Dr. Vicente Soriano
Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure

Article • AIDS Research and Therapy, January 2012, Springer Science + Business Media

Dr. Vicente Soriano
Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor

Article • Antiviral Therapy, January 2012, International Medical Press

Dr. Vicente Soriano
Highly pathogenic avian influenza virus H5N1 controls type I IFN induction in chicken macrophage HD-11 cells: a polygenic trait that involves NS1 and the polymerase complex

Article • Virology Journal, January 2012, Springer Science + Business Media

Enrique J. Calderon, Dr. Vicente Soriano
Pharmacogenetics of hepatitis C

Article • Journal of Antimicrobial Chemotherapy, December 2011, Oxford University Press (OUP)

Dr. Vicente Soriano
Comparison of HIV-1 RNA Measurements Obtained by Using Plasma and Dried Blood Spots in the Automated Abbott Real-Time Viral Load Assay

Article • Journal of Clinical Microbiology, December 2011, ASM Journals

Dr. Vicente Soriano
Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia in HIV/HCV-Coinfected Patients With All HCV Genotypes

Article • The Journal of Infectious Diseases, December 2011, Oxford University Press (OUP)

Dr. Vicente Soriano
Most HIV Type 1 Non-B Infections in the Spanish Cohort of Antiretroviral Treatment-Naive HIV-Infected Patients (CoRIS) Are Due to Recombinant Viruses

Article • Journal of Clinical Microbiology, December 2011, ASM Journals

Dr. Vicente Soriano
Longitudinal Assessment of Interleukin 7 Plasma Levels in HIV-Infected Patients in the Absence of and Under Antiretroviral Therapy

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2011, Wolters Kluwer Health

Dr. Vicente Soriano
Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy

Article • Journal of Infection, November 2011, Elsevier

Dr. Vicente Soriano
Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata

Article • AIDS, November 2011, Wolters Kluwer Health

Dr. Vicente Soriano
La cohorte de la red española de investigación en sida y su biobanco: organización, principales resultados y pérdidas al seguimiento

Article • Enfermedades Infecciosas y Microbiología Clínica, November 2011, Elsevier

Dr. Vicente Soriano
Challenges and opportunities for hepatitis C drug development in HIV–hepatitis C virus-co-infected patients

Article • AIDS, November 2011, Wolters Kluwer Health

Dr. Vicente Soriano
Host genetics

Article • Current Opinion in HIV and AIDS, November 2011, Wolters Kluwer Health

Dr. Vicente Soriano
Infección por virus de la inmunodeficiencia humana y hepatitis víricas

Article • Enfermedades Infecciosas y Microbiología Clínica, November 2011, Elsevier

Dr. Vicente Soriano
Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C

Article • Clinical Infectious Diseases, October 2011, Oxford University Press (OUP)

Dr. Vicente Soriano
The expansion ability but not the quality of HIV-specific CD8+ T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors

Article • Immunology, October 2011, Wiley

Dr. Vicente Soriano
HTLV infection among foreign pregnant women living in Spain

Article • Journal of Clinical Virology, October 2011, Elsevier

Dr. Vicente Soriano
Hepatitis delta in HIV-infected individuals in Europe

Article • AIDS, October 2011, Wolters Kluwer Health

Dr. Vicente Soriano
Profilaxis preexposición en la prevención de la infección por virus de la inmunodeficiencia humana

Article • Medicina Clínica, October 2011, Elsevier

Dr. Vicente Soriano
Response to: “Is the Study Power Enough to Say ‘No Difference’?” by Geib et al

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2011, Wolters Kluwer Health

Dr. Vicente Soriano
Short Communication: Use of Serum Bilirubin Levels as Surrogate Marker of Early Virological Response to Atazanavir-Based Antiretroviral Therapy

Article • AIDS Research and Human Retroviruses, October 2011, Mary Ann Liebert Inc

Dr. Vicente Soriano
Antiviral effect of raltegravir on HTLV-1 carriers

Article • Journal of Antimicrobial Chemotherapy, September 2011, Oxford University Press (OUP)

Dr. Vicente Soriano
Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients

Article • Journal of Antimicrobial Chemotherapy, September 2011, Oxford University Press (OUP)

Dr. Vicente Soriano
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility

Article • Nature Genetics, September 2011, Springer Science + Business Media

Professor Ulla B Vogel, Dr Karina Banasik, Dr. Vicente Soriano
A376S in the Connection Subdomain of HIV-1 Reverse Transcriptase Confers Increased Risk of Virological Failure to Nevirapine Therapy

Article • The Journal of Infectious Diseases, September 2011, Oxford University Press (OUP)

Dr. Vicente Soriano
Short Communication: Severe Immune Suppression in Patients Infected with R5-Tropic HIV-1 Strains Is Associated with Increased gp120 Net Charge at Variable Regions

Article • AIDS Research and Human Retroviruses, September 2011, Mary Ann Liebert Inc

Dr. Vicente Soriano
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*

Article • Journal of Viral Hepatitis, August 2011, Wiley

Dr. Vicente Soriano
An International Collaboration To Standardize HIV-2 Viral Load Assays: Results from the 2009 ACHIEV2E Quality Control Study

Article • Journal of Clinical Microbiology, August 2011, ASM Journals

Dr. Vicente Soriano
Comparison of Two Serological Tests for the Identification of Recent HIV Infection: Vironostika HIV-1 Microelisa and BED Capture Enzyme Immunoassay

Article • Enfermedades Infecciosas y Microbiología Clínica, August 2011, Elsevier

Dr Jesus Almeda, Dr. Vicente Soriano
High Concordance between the Position-Specific Scoring Matrix and Geno2pheno Algorithms for Genotypic Interpretation of HIV-1 Tropism: V3 Length as the Major Cause of Disagreement: Table 1.

Article • Journal of Clinical Microbiology, July 2011, ASM Journals

Dr. Vicente Soriano
Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: The INSIGHT FLU 002 and FLU 003 studies

Article • Vaccine, July 2011, Elsevier

Dr. Vicente Soriano
Genetic Variants of ABCC10, a Novel Tenofovir Transporter, Are Associated With Kidney Tubular Dysfunction

Article • The Journal of Infectious Diseases, July 2011, Oxford University Press (OUP)

Neill Liptrott, Dr. Vicente Soriano
Tuberculosis among HIV-positive patients across Europe

Article • AIDS, July 2011, Wolters Kluwer Health

Dr. Vicente Soriano
Seroprevalence of HTLV infection among immigrant pregnant women in the Mediterranean coast of Spain

Article • Journal of Clinical Virology, July 2011, Elsevier

Dr. Vicente Soriano
Directly acting antivirals against hepatitis C virus

Article • Journal of Antimicrobial Chemotherapy, June 2011, Oxford University Press (OUP)

Dr. Vicente Soriano
Prevalence and changing distribution of HTLV-1 and HTLV-2 infections in Spain

Article • Retrovirology, June 2011, Springer Science + Business Media

Dr. Vicente Soriano
Seroprevalence of HTLV infection in Spain among immigrant pregnant women

Article • Retrovirology, June 2011, Springer Science + Business Media

Dr. Vicente Soriano
Treatment with Raltegravir, a retroviral integrase inhibitor, in patients infected with HTLV-1

Article • Retrovirology, June 2011, Springer Science + Business Media

Dr. Vicente Soriano
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

Article • AIDS, June 2011, Wolters Kluwer Health

Dr. Vicente Soriano
Changing Rate of Non-B Subtypes and Coinfection with Hepatitis B/C Viruses in Newly Diagnosed HIV Type 1 Individuals in Spain

Article • AIDS Research and Human Retroviruses, June 2011, Mary Ann Liebert Inc

Dr. Vicente Soriano
Influence of Interleukin-28B Single-Nucleotide Polymorphisms on Progression to Liver Cirrhosis in Human Immunodeficiency Virus–Hepatitis C Virus–Coinfected Patients Receiving Antiretroviral Therapy

Article • The Journal of Infectious Diseases, June 2011, Oxford University Press (OUP)

Dr. Vicente Soriano
Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients – Impact of HIV subtypes and prior raltegravir experience

Article • Antiviral Research, June 2011, Elsevier

Dr. Vicente Soriano
Perspectivas futuras en el tratamiento de la hepatitis crónica C

Article • Revista Española de Sanidad Penitenciaria, June 2011, Instituto de Salud Carlos III/BNCS/SciELO Espana

Dr. Vicente Soriano
Novel Method for Simultaneous Quantification of Phenotypic Resistance to Maturation, Protease, Reverse Transcriptase, and Integrase HIV Inhibitors Based on 3′Gag(p2/p7/p1/p6)/PR/RT/INT-Recombinant Viruses: a Useful Tool in the Multitarget Era of Antire...

Article • Antimicrobial Agents and Chemotherapy, May 2011, ASM Journals

Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu
Impact of Baseline HIV-1 Tropism on Viral Response and CD4 Cell Count Gains in HIV-Infected Patients Receiving First-line Antiretroviral Therapy

Article • The Journal of Infectious Diseases, May 2011, Oxford University Press (OUP)

Dr. Vicente Soriano
Drug resistance mutations in patients infected with HIV-2 living in Spain

Article • Journal of Antimicrobial Chemotherapy, May 2011, Oxford University Press (OUP)

Dr. Vicente Soriano
HIV and the Liver

Article • May 2011, Wiley

Dr. Vicente Soriano
Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

Article • AIDS, May 2011, Wolters Kluwer Health

Dr. Vicente Soriano
European guidelines on the clinical management of HIV-1 tropism testing

Article • The Lancet Infectious Diseases, May 2011, Elsevier

Dr. Vicente Soriano
HCV-Specific T-Cell Responses in HIV/Hepatitis C Virus-Coinfected Patients on Highly Active Antiretroviral Therapy Are Comparable to Those Observed in Hepatitis C Virus-Monoinfected Individuals

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, May 2011, Wolters Kluwer Health

Dr. Vicente Soriano
IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin

Article • AIDS, May 2011, Wolters Kluwer Health

Dr. Vicente Soriano
Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors

Article • Clinical Immunology, May 2011, Elsevier

Dr. Vicente Soriano
XMRV, un nuevo retrovirus humano en busca de enfermedad

Article • Medicina Clínica, May 2011, Elsevier

Dr. Vicente Soriano
Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)

Article • HIV Medicine, April 2011, Wiley

Dr. Vicente Soriano
Immunovirological Response to Triple Nucleotide Reverse-Transcriptase Inhibitors and Ritonavir-Boosted Protease Inhibitors in Treatment-Naive HIV-2-Infected Patients: The ACHIEV2E Collaboration Study Group

Article • Clinical Infectious Diseases, April 2011, Oxford University Press (OUP)

Dr. Vicente Soriano
Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients

Article • Journal of Viral Hepatitis, April 2011, Wiley

Dr. Vicente Soriano
A Standardized Algorithm for Determining the Underlying Cause of Death in HIV Infection as AIDS or non-AIDS Related: Results from the EuroSIDA Study

Article • HIV Clinical Trials, April 2011, Taylor & Francis

Dr. Vicente Soriano
New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B

Article • AIDS, April 2011, Wolters Kluwer Health

Dr. Vicente Soriano
Documento de consenso de GESIDA/ Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero 2011)

Article • Enfermedades Infecciosas y Microbiología Clínica, March 2011, Elsevier

Dr. Vicente Soriano
Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype

Article • HIV Medicine, March 2011, Wiley

Dr. Vicente Soriano
Characterization of host genetic expression patterns in HIV-infected individuals with divergent disease progression

Article • Virology, March 2011, Elsevier

Dr. Vicente Soriano
Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients

Article • AIDS, March 2011, Wolters Kluwer Health

Dr. Vicente Soriano
1168 SURVIVAL OF HIV AND HIV/HCV CO-INFECTED PATIENTS WITHIN INTENSIVE CARE UNIT (ICU) IN THE MOST RECENT HAART ERA

Article • Journal of Hepatology, March 2011, Elsevier

Dr. Vicente Soriano
1230 IMPACT OF ANTIRETROVIRAL THERAPY ON THE VARIABILITY OF THE HCV NS5B POLYMERASE IN HIV/HCV COINFECTED PATIENTS

Article • Journal of Hepatology, March 2011, Elsevier

Dr. Vicente Soriano
1335 IL28B POLYMORPHISM IN HIV-POSITIVE PATIENTS WITH ACUTE HEPATITIS C

Article • Journal of Hepatology, March 2011, Elsevier

Dr. Vicente Soriano
1321 DIFFERENT INFLUENCE OF HCV-SPECIFIC T-CELL RESPONSES AND RS12979860 IL28B GENOTYPES ON KINETICS OF HCV CLEARANCE IN PATIENTS TREATED WITH PEGINTERFERON-RIBAVIRIN

Article • Journal of Hepatology, March 2011, Elsevier

Dr. Vicente Soriano
354 LIVER FIBROSIS PROGRESSION IN HIV+ PATIENTS UNDER DISTINCT ANTIRETROVIRAL DRUGS

Article • Journal of Hepatology, March 2011, Elsevier

Dr. Vicente Soriano
1338 WHOLE GENOME EXPRESSION PROFILE DEFINES DIFFERENTIALLY EXPRESSED GENES IN HIV/HCV-COINFECTED PATIENTS ACCORDING TO PEGIFNA/RBV TREATMENT OUTCOME AND TO IL28B GENOTYPE

Article • Journal of Hepatology, March 2011, Elsevier

Dr. Vicente Soriano
Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients

Article • Expert Opinion on Drug Metabolism & Toxicology, February 2011, Informa Healthcare

Dr. Vicente Soriano
Elite Controllers Display Higher Activation on Central Memory CD8 T Cells Than HIV Patients Successfully on HAART

Article • AIDS Research and Human Retroviruses, February 2011, Mary Ann Liebert Inc

Dr. Vicente Soriano
Noncirrhotic portal hypertension in HIV infection

Article • Current Opinion in Infectious Diseases, February 2011, Wolters Kluwer Health

Dr. Vicente Soriano
Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

Article • Journal of Antimicrobial Chemotherapy, January 2011, Oxford University Press (OUP)

Dr. Vicente Soriano
HCV and HIV Coinfection

Article • Current Hepatology Reports, January 2011, Springer Science + Business Media

Dr. Vicente Soriano
A Highly Sensitive and Specific Model for Predicting HIV-1 Tropism in Treatment-Experienced Patients Combining Interpretation of V3 Loop Sequences and Clinical Parameters

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2011, Wolters Kluwer Health

Dr Mar Masiá, Blanca Lumbreras, Dr. Vicente Soriano
Sub-Cellular Distribution and Translocation of TRP Channels

Article • Current Pharmaceutical Biotechnology, January 2011, Bentham Science Publishers

Dr. Vicente Soriano
Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care

Article • Antiviral Therapy, January 2011, International Medical Press

Dr. Vicente Soriano
Predicted effect of direct acting antivirals in the current HIV–HCV-coinfected population in Spain

Article • Antiviral Therapy, January 2011, International Medical Press

Dr. Vicente Soriano
Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues

Article • AIDS, January 2011, Wolters Kluwer Health

Dr. Vicente Soriano
HBV primary drug resistance in newly diagnosed HIV–HBV-coinfected individuals in Spain

Article • Antiviral Therapy, January 2011, International Medical Press

Dr. Vicente Soriano
Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study

Article • Antiviral Therapy, January 2011, International Medical Press

Dr. Vicente Soriano
Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline

Article • AIDS, January 2011, Wolters Kluwer Health

Dr. Vicente Soriano
Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV–HCV-coinfected patients

Article • Antiviral Therapy, January 2011, International Medical Press

Dr. Vicente Soriano
Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial

Article • Antiviral Therapy, January 2011, International Medical Press

Dr. Vicente Soriano
Resistance data in the ARTEN trial

Article • Antiviral Therapy, January 2011, International Medical Press

Dr. Vicente Soriano
Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS)

Article • Antiviral Research, January 2011, Elsevier

Dr. Vicente Soriano
Infrared Focal Plane Array Imaging System Characterization by Means of a Blackbody Radiator

Article • January 2011, Springer Science + Business Media

Dr. Vicente Soriano
Resistance data in the ARTEN trial

Article • Antiviral Therapy, January 2011, SAGE Publications

Dr. Vicente Soriano
Detection of hepatitis B virus genotype A3 and primary drug resistance mutations in African immigrants with chronic hepatitis B in Spain

Article • Journal of Antimicrobial Chemotherapy, December 2010, Oxford University Press (OUP)

Dr. Vicente Soriano
Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance

Article • Journal of Viral Hepatitis, December 2010, Wiley

Dr. Vicente Soriano
Acute hepatitis C in HIV-infected individuals – recommendations from the NEAT consensus conference

Article • AIDS, December 2010, Wolters Kluwer Health

Dr. Vicente Soriano
Dialysis and Renal Transplantation in HIV-Infected Patients: a European Survey

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2010, Wolters Kluwer Health

Dr. Vicente Soriano
Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIV

Article • Clinical Infectious Diseases, November 2010, Oxford University Press (OUP)

Dr. Vicente Soriano
Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes

Article • Journal of Viral Hepatitis, November 2010, Wiley

Dr. Vicente Soriano
Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy

Article • Journal of the International AIDS Society, November 2010, Wiley

Dr Victor Asensi, Dr. Vicente Soriano
Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants

Article • Antiviral Research, November 2010, Elsevier

Dr. Vicente Soriano
Efficacy of Exercise in Reducing Depressive Symptoms across 5-HTTLPR Genotypes

Article • Medicine & Science in Sports & Exercise, November 2010, Wolters Kluwer Health

Dr. Vicente Soriano
Influence of a Single Nucleotide Polymorphism at the Main Ribavirin Transporter Gene on the Rapid Virological Response to Pegylated Interferon–Ribavirin Therapy in Patients with Chronic Hepatitis C Virus Infection

Article • The Journal of Infectious Diseases, October 2010, Oxford University Press (OUP)

Dr. Vicente Soriano
Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patients

Article • Journal of Antimicrobial Chemotherapy, October 2010, Oxford University Press (OUP)

Dr. Vicente Soriano
Near-Membrane Dynamics and Capture of TRPM8 Channels within Transient Confinement Domains

Article • PLoS ONE, October 2010, PLOS

Dr. Vicente Soriano
Population Pharmacokinetic Modeling of the Association between 63396C→T Pregnane X Receptor Polymorphism and Unboosted Atazanavir Clearance

Article • Antimicrobial Agents and Chemotherapy, October 2010, ASM Journals

Dr. Vicente Soriano
Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study

Article • European Journal of Cardiovascular Prevention & Rehabilitation, October 2010, SAGE Publications

Dr. Vicente Soriano
Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2010, Wolters Kluwer Health

Dr. Vicente Soriano
European guideline for the management of hepatitis B and C virus infections, 2010

Article • International Journal of STD & AIDS, October 2010, SAGE Publications

Dr. Vicente Soriano
Elevated TGF-β1 levels might protect HCV/ HIV-coinfected patients from liver fibrosis

Article • European Journal of Clinical Investigation, September 2010, Wiley

Dr. Vicente Soriano
Evolution of the Functional Profile of HIV-Specific CD8+ T Cells in Patients With Different Progression of HIV Infection Over 4 Years

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, September 2010, Wolters Kluwer Health

Dr. Vicente Soriano
Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis

Article • Journal of Viral Hepatitis, August 2010, Wiley

Dr. Vicente Soriano
A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study

Article • HIV Medicine, August 2010, Wiley

Dr. Vicente Soriano
Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT)

Article • HIV Medicine, August 2010, Wiley

Dr. Vicente Soriano
Situación actual de la infección por el virus de la inmunodeficiencia humana tipo 2 y el Virus linfotrópico de células T humano en España

Article • Enfermedades Infecciosas y Microbiología Clínica, August 2010, Elsevier

Dr. Vicente Soriano
Prevalence of HTLV-1/2 Infections in Spain: A Cross-Sectional Hospital-Based Survey

Article • AIDS Research and Human Retroviruses, August 2010, Mary Ann Liebert Inc

Dr. Vicente Soriano, Enrique J. Calderon
RETRACTED ARTICLE: Simplification From Protease Inhibitors to Once- or Twice-Daily Raltegravir: The ODIS Trial

Article • HIV Clinical Trials, August 2010, Taylor & Francis

Dr. Vicente Soriano
Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies

Article • Cancer, July 2010, Wiley

Dr. Vicente Soriano
High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists--authors' response

Article • Journal of Antimicrobial Chemotherapy, July 2010, Oxford University Press (OUP)

Dr. Vicente Soriano
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study

Article • The Lancet, July 2010, Elsevier

Dr. Vicente Soriano
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

Article • AIDS, July 2010, Wolters Kluwer Health

Dr. Vicente Soriano
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs

Article • The Lancet, July 2010, Elsevier

Dr. Vicente Soriano
Resistance to Integrase Inhibitors

Article • Viruses, June 2010, MDPI AG

Dr. Vicente Soriano
Low-Level Exposure to HIV Induces Virus-Specific T Cell Responses and Immune Activation in Exposed HIV-Seronegative Individuals

Article • The Journal of Immunology, June 2010, The American Association of Immunologists

Dr. Vicente Soriano
Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701

Article • Journal of Antimicrobial Chemotherapy, June 2010, Oxford University Press (OUP)

Dr. Vicente Soriano
Documento de consenso del Grupo de Estudio de Sida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero 2010)

Article • Enfermedades Infecciosas y Microbiología Clínica, June 2010, Elsevier

Dr. Vicente Soriano
Nuevos retrovirus humanos

Article • Medicina Clínica, June 2010, Elsevier

Dr. Vicente Soriano
Infección por el virus de la inmunodeficiencia humana de tipo 2 (VIH-2) y los virus linfotrópico humano de células T de tipos 1 y 2 (HTLV-1/2) en España

Article • Medicina Clínica, June 2010, Elsevier

Dr. Vicente Soriano
Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia

Article • Journal of Antimicrobial Chemotherapy, May 2010, Oxford University Press (OUP)

Dr. Vicente Soriano
Plitidepsin (APL) alone or with dacarbazine (DTIC) as first-line treatment for advanced unresectable melanoma (AUM).

Article • Journal of Clinical Oncology, May 2010, American Society of Clinical Oncology (ASCO)

Dr. Vicente Soriano
Drug Resistance Mutations in HIV-Infected Patients in the Spanish Drug Resistance Database Failing Tipranavir and Darunavir Therapy

Article • Antimicrobial Agents and Chemotherapy, May 2010, ASM Journals

Dr. Vicente Soriano
Glomerular filtration (GF) determined by creatinine clearance (CCR) in 24 hours urine and cockcroft & gault (cg) and modification of diet in renal disease (MDRD) equations in a large cohort of HIV+ patients

Article • Retrovirology, May 2010, Springer Science + Business Media

Dr. Vicente Soriano
Hepatitis B: treatment strategies and resistance

Article • Retrovirology, May 2010, Springer Science + Business Media

Dr. Vicente Soriano
Tenofovir (TDF) containing first-line HAART is associated with changes in plasma parameters suggestive of increased bone resorption

Article • Retrovirology, May 2010, Springer Science + Business Media

Dr. Vicente Soriano
Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients

Article • AIDS, May 2010, Wolters Kluwer Health

Dr. Vicente Soriano
Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings

Article • AIDS, May 2010, Wolters Kluwer Health

Dr. Vicente Soriano
High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists

Article • Journal of Antimicrobial Chemotherapy, April 2010, Oxford University Press (OUP)

Dr. Vicente Soriano
Renal toxicity associated with tenofovir use

Article • Expert Opinion on Drug Safety, April 2010, Informa Healthcare

Dr. Vicente Soriano
Long-Term Efficacy and Safety of the HIV Integrase Inhibitor Raltegravir in Patients With Limited Treatment Options in a Phase II Study

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2010, Wolters Kluwer Health

Dr. Vicente Soriano
Infección por el virus de la inmunodeficiencia humana en diferentes grupos de edad: implicaciones potenciales para la prevención. Cohorte CoRIS, España, 2004–2008

Article • Medicina Clínica, April 2010, Elsevier

Dr. Vicente Soriano
Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations

Article • AIDS, April 2010, Wolters Kluwer Health

Dr. Vicente Soriano
Preemptive Erythropoietin Plus High Ribavirin Doses to Increase Rapid Virological Responses in HIV Patients Treated for Chronic Hepatitis C

Article • AIDS Research and Human Retroviruses, April 2010, Mary Ann Liebert Inc

Dr. Vicente Soriano
275 TREATMENT OF CHRONIC HEPATITIS C IN HIV-INFECTED PATIENTS WITH COMPENSATED LIVER CIRRHOSIS

Article • Journal of Hepatology, April 2010, Elsevier

Dr. Vicente Soriano
1008 KIDNEY TUBULAR DYSFUNCTION (KTD) IN PATIENTS WITH PROLONGED EXPOSURE TO TENOFOVIR (TDF): A PROSPECTIVE STUDY

Article • Journal of Hepatology, April 2010, Elsevier

Dr. Vicente Soriano
1159 NON-CIRRHOTIC PORTAL HYPERTENSION IN HIV-INFECTED PATIENTS: UNIQUE CLINICAL AND PATHOLOGICAL FEATURES

Article • Journal of Hepatology, April 2010, Elsevier

Dr. Vicente Soriano
1160 HEPATIC SAFETY PROFILE OF NEW ANTIRETROVIRAL DRUGS IN HIV-INFECTED PATIENTS WITH CHRONIC HEPATITIS C

Article • Journal of Hepatology, April 2010, Elsevier

Dr. Vicente Soriano
282 A SPECIFIC HAPLOTYPE AT THE ENT1 GENE INFLUENCES THE RATE OF SUSTAINED VIROLOGICAL RESPONSE TO PEGINTERFERON-RIBAVIRIN IN HIV/HCV-COINFECTED PATIENTS

Article • Journal of Hepatology, April 2010, Elsevier

Dr. Vicente Soriano
715 ASSESSMENT OF THE VIROLOGICAL PROFILES OF UNTREATED PATIENTS WITH CHRONIC HEPATITIS DELTA (CHD) REQUIRES LONGITUDINAL MEASUREMENTS OF HBV DNA AND HDV RNA

Article • Journal of Hepatology, April 2010, Elsevier

Dr. Vicente Soriano
743 NATURALLY OCCURRING DRUG RESISTANCE MUTATIONS IN THE HEPATITIS C VIRUS NS3 PROTEASE IN HIV/HCV COINFECTED PATIENTS TREATED WITH HIV PROTEASE INHIBITORS

Article • Journal of Hepatology, April 2010, Elsevier

Dr. Vicente Soriano
1085 VIRAL HEPATITIS B AND C IN NEWLY DIAGNOSED HIV-1 INDIVIDUALS IN SPAIN – A NATIONAL SURVEY SINCE YEAR 2000

Article • Journal of Hepatology, April 2010, Elsevier

Dr. Vicente Soriano
Frequent hepatitis B virus rebound among HIV–hepatitis B virus-coinfected patients following antiretroviral therapy interruption

Article • AIDS, March 2010, Wolters Kluwer Health

Dr. Vicente Soriano
Human immunodeficiency virus and liver disease: Conference proceedings

Article • Hepatology, March 2010, Wiley

Dr. Vicente Soriano
Rate and Predictors of Success in the Retreatment of Chronic Hepatitis C Virus in HIV/Hepatitis C Virus Coinfected Patients With Prior Nonresponse or Relapse

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2010, Wolters Kluwer Health

Dr. Vicente Soriano
Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients

Article • AIDS, March 2010, Wolters Kluwer Health

Dr. Vicente Soriano
Survival of HIV-infected patients with compensated liver cirrhosis

Article • AIDS, March 2010, Wolters Kluwer Health

Dr. Vicente Soriano
The Benefit of Simplification From Tipranavir/Ritonavir 500/200 bid to 500/100 bid Guided by Therapeutic Drug Monitoring

Article • Therapeutic Drug Monitoring, March 2010, Wolters Kluwer Health

Dr. Vicente Soriano
Long‐Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment‐Experienced Patients with Drug‐Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials

Article • Clinical Infectious Diseases, February 2010, Oxford University Press (OUP)

Dr. Vicente Soriano
History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change

Article • HIV Medicine, February 2010, Wiley

Dr. Vicente Soriano
Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C

Article • Antimicrobial Agents and Chemotherapy, January 2010, ASM Journals

Dr. Vicente Soriano
New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients

Article • Journal of Antimicrobial Chemotherapy, January 2010, Oxford University Press (OUP)

Dr. Vicente Soriano
Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe

Article • Journal of Antimicrobial Chemotherapy, January 2010, Oxford University Press (OUP)

Dr. Vicente Soriano
Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV-1-infected patients with undetectable viremia

Article • Journal of the International AIDS Society, January 2010, Wiley

Dr. Vicente Soriano
Impact of baseline HIV-1 tropism on viral response and CD4 gains in antiretroviral-naïve patients

Article • Journal of the International AIDS Society, January 2010, Wiley

Dr. Vicente Soriano
Consensus statement of the European guidelines on clinical management of HIV-1 tropism testing

Article • Journal of the International AIDS Society, January 2010, Wiley

Dr. Vicente Soriano
Do interleukin-28B single nucleotide polymorphisms influence the natural history of chronic hepatitis B?

Article • Journal of the International AIDS Society, January 2010, Wiley

Dr. Vicente Soriano
No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV

Article • Journal of the International AIDS Society, January 2010, Wiley

Dr. Vicente Soriano
Efficacy and safety of TDF+FTC+EFV in naïve patients initiating HAART; an observational study comparing Atripla Vs Truvada/Sustiva exposure

Article • Retrovirology, January 2010, Springer Science + Business Media

Dr. Vicente Soriano
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

Article • AIDS, January 2010, Wolters Kluwer Health

Dr. Vicente Soriano
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

Article • AIDS, January 2010, Wolters Kluwer Health

Dr. Vicente Soriano
Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database

Article • AIDS, January 2010, Wolters Kluwer Health

Dr. Vicente Soriano
High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor

Article • AIDS, January 2010, Wolters Kluwer Health

Dr. Vicente Soriano
Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy

Article • Antiviral Therapy, January 2010, International Medical Press

Dr. Vicente Soriano
Viral hepatitis and HIV co-infection

Article • Antiviral Research, January 2010, Elsevier

Dr. Vicente Soriano
TRPM8 Near-Membrane Dynamics and Channel Stabilization after Stimulation

Article • Biophysical Journal, January 2010, Elsevier

Dr. Vicente Soriano
Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C

Article • Journal of Antimicrobial Chemotherapy, December 2009, Oxford University Press (OUP)

Dr. Vicente Soriano
New therapeutic strategies for raltegravir

Article • Journal of Antimicrobial Chemotherapy, December 2009, Oxford University Press (OUP)

Dr. Vicente Soriano
Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection

Article • Journal of Antimicrobial Chemotherapy, December 2009, Oxford University Press (OUP)

Dr. Vicente Soriano
Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations

Article • Journal of Viral Hepatitis, December 2009, Wiley

Dr. Vicente Soriano
Short Communication: Transmission of Hepatitis B Viruses with Lamivudine Resistance Mutations in Newly Diagnosed HIV Individuals

Article • AIDS Research and Human Retroviruses, December 2009, Mary Ann Liebert Inc

Dr. Vicente Soriano
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection

Article • Journal of Viral Hepatitis, November 2009, Wiley

Dr. Vicente Soriano
Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV‐Infected and HIV‐Uninfected Patients

Article • Clinical Infectious Diseases, November 2009, Oxford University Press (OUP)

Dr. Vicente Soriano
El desafío de la nueva gripe A/H1N1

Article • Medicina Clínica, November 2009, Elsevier

Dr. Vicente Soriano
When and how to use maraviroc in HIV-infected patients

Article • AIDS, November 2009, Wolters Kluwer Health

Dr. Vicente Soriano
Interleukin-2 Therapy in Patients with HIV Infection

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2009, New England Journal of Medicine (NEJM/MMS)

Dr. Vicente Soriano
Fe de errores de “Recomendaciones de Gesida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización febrero de 2009)”

Article • Enfermedades Infecciosas y Microbiología Clínica, October 2009, Elsevier

Dr. Vicente Soriano
Changes in Drug Resistance Patterns following the Introduction of HIV Type 1 Non-B Subtypes in Spain

Article • AIDS Research and Human Retroviruses, October 2009, Mary Ann Liebert Inc

Dr. Vicente Soriano
Mutation N155H in HIV-2 integrase confers high phenotypic resistance to raltegravir and impairs replication capacity

Article • Journal of Clinical Virology, October 2009, Elsevier

Dr. Vicente Soriano
Pharmacogenetics of tenofovir treatment

Article • Pharmacogenomics, October 2009, Future Medicine

Dr. Vicente Soriano
Rate of Accumulation of Thymidine Analogue Mutations in Patients Continuing to Receive Virologically Failing Regimens Containing Zidovudine or Stavudine: Implications for Antiretroviral Therapy Programs in Resource‐Limited Settings

Article • The Journal of Infectious Diseases, September 2009, Oxford University Press (OUP)

Dr. Vicente Soriano
First HAART in HIV-Infected Patients With High Viral Load: Value of HIV RNA Levels at 12 Weeks to Predict Virologic Outcome

Article • Journal of the International Association of Providers of AIDS Care (JIAPAC), September 2009, SAGE Publications

Dr. Vicente Soriano
Update on HIV viral-load assays: new technologies and testing in resource-limited settings

Article • Future Virology, September 2009, Future Medicine

Dr. Vicente Soriano
Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy

Article • AIDS, August 2009, Wolters Kluwer Health

Dr. Vicente Soriano
Actualización sobre las infecciones por el virus de la inmunodeficiencia humana de tipo 2 y por los virus linfotrópico humano de tipo 1 y de tipo 2 en España

Article • Enfermedades Infecciosas y Microbiología Clínica, August 2009, Elsevier

Dr. Vicente Soriano
Use of Different Inhibitory Quotients To Predict Early Virological Response to Tipranavir in Antiretroviral-Experienced Human Immunodeficiency Virus-Infected Patients

Article • Antimicrobial Agents and Chemotherapy, July 2009, ASM Journals

Dr. Vicente Soriano
HIV protease inhibitors: recent clinical trials and recommendations on use

Article • Expert Opinion on Pharmacotherapy, June 2009, Informa Healthcare

Dr. Vicente Soriano
Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance

Article • Journal of Antimicrobial Chemotherapy, June 2009, Oxford University Press (OUP)

Dr. Vicente Soriano
Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study

Article • Clinical Infectious Diseases, June 2009, Oxford University Press (OUP)

Dr. Vicente Soriano
Seroprevalence of HTLV-1/2 Infection among Native and Immigrant Pregnant Women in Spain

Article • AIDS Research and Human Retroviruses, June 2009, Mary Ann Liebert Inc

Dr. Vicente Soriano, Enrique J. Calderon
Seroreversion of Hepatitis C Virus (HCV) Antibodies in an HIV‐Infected Patient despite Continuous HCV Replication

Article • Clinical Infectious Diseases, June 2009, Oxford University Press (OUP)

Dr. Vicente Soriano
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

Article • Retrovirology, May 2009, Springer Science + Business Media

Dr Dimitrios Paraskevis, Dr. Vicente Soriano
Reply to Pascual Pareja et al.

Article • The Journal of Infectious Diseases, May 2009, Oxford University Press (OUP)

Dr. Vicente Soriano
The role of injection versus socioeconomic factors in hepatitis A virus infection among young heroin users: Implications for vaccination policies

Article • Vaccine, May 2009, Elsevier

Dr. Vicente Soriano
Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools

Article • Journal of Medical Virology, May 2009, Wiley

Dr. Vicente Soriano
Metodología de reclutamiento y características de una cohorte de jóvenes consumidores habituales de cocaína de tres ciudades españolas (Proyecto Itínere-cocaína)

Article • Gaceta Sanitaria, May 2009, Elsevier

Dr. Vicente Soriano
Variable Impact on Mortality of AIDS‐Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS‐Defining Conditions Are Created Equal

Article • Clinical Infectious Diseases, April 2009, Oxford University Press (OUP)

Dr. Vicente Soriano
227 NON-CIRRHOTIC PORTAL HYPERTENSION IN HIV-INFECTED PATIENTS

Article • Journal of Hepatology, April 2009, Elsevier

Dr Victor Asensi, Dr. Vicente Soriano
Differences in Lopinavir Plasma Concentrations Comparing Kaletra® Film Coated Tablets and Soft Gelatine Capsules That Result in Various Lipid Abnormalities

Article • Drug Metabolism Letters, April 2009, Bentham Science Publishers

Dr. Vicente Soriano
Recomendaciones de Gesida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización febrero de 2009)

Article • Enfermedades Infecciosas y Microbiología Clínica, April 2009, Elsevier

Dr. Vicente Soriano
Hepatitis C Virus Coinfection Does Not Influence the CD4 Cell Recovery in HIV-1-Infected Patients With Maximum Virologic Suppression

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2009, Wolters Kluwer Health

Dr. Vicente Soriano
Liver Complications Have Reached a Plateau as Cause of Hospital Admission and Death in HIV Patients in Madrid

Article • AIDS Research and Human Retroviruses, April 2009, Mary Ann Liebert Inc

Dr. Vicente Soriano
Transmisión vertical del virus de la inmunodeficiencia humana en la era del tratamiento antirretroviral de gran actividad

Article • Medicina Clínica, April 2009, Elsevier

Dr. Vicente Soriano
343 NO EVIDENCE FOR LOW-LEVEL HCV REPLICATION OR SIGNIFICANT LIVER FIBROSIS IN HIV PATIENTS WHO SPONTANEOUSLY CLEARED HCV INFECTION

Article • Journal of Hepatology, April 2009, Elsevier

Dr. Vicente Soriano
648 DIFFERENCES IN ANTIVIRAL ACTIVITY AND TOLERABILITY BETWEEN PEGYLATED INTERFERON ALPHA – 2A AND – 2B IN HIV INFECTED PATIENTS WITH CHRONIC HEPATITIS C

Article • Journal of Hepatology, April 2009, Elsevier

Dr. Vicente Soriano
888 ASSOCIATION BETWEEN NAIVE REGULATORY T (TREG) CELLS AND HCV-SPECIFIC IMMUNE RESPONSES IN PATIENTS WITH CHRONIC HEPATITIS C

Article • Journal of Hepatology, April 2009, Elsevier

Dr. Vicente Soriano
887 HCV-SPECIFIC T CELL RESPONSE IN PATIENTS WITH CHRONIC HIV/HCV CO-INFECTION IS NOT DEPENDENT OF HCV GENOTYPE

Article • Journal of Hepatology, April 2009, Elsevier

Dr. Vicente Soriano
411 HEPATITIS C VIRUS REAPPEARANCE IN HIV-INFECTED PATIENTS WITH SPONTANEOUS HCV-RNA CLEARANCE

Article • Journal of Hepatology, April 2009, Elsevier

Dr. Vicente Soriano
Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists

Article • Journal of Antimicrobial Chemotherapy, March 2009, Oxford University Press (OUP)

Dr. Vicente Soriano
Delayed Diagnosis of HIV Infection in a Multicenter Cohort: Prevalence, Risk Factors, Response to HAART and Impact on Mortality

Article • Current HIV Research, March 2009, Bentham Science Publishers

Dr. Vicente Soriano
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

Article • AIDS, March 2009, Wolters Kluwer Health

Dr. Vicente Soriano
Lack of Significant Cross-Reactivity for HIV-2 Immunoblots in HIV-1-Infected Patients

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2009, Wolters Kluwer Health

Dr. Vicente Soriano
Correlation between Human Immunodeficiency Virus Type 1 (HIV-1) RNA Measurements Obtained with Dried Blood Spots and Those Obtained with Plasma by Use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV Load Tests

Article • Journal of Clinical Microbiology, February 2009, ASM Journals

Dr. Vicente Soriano
Fourth HIV & Hepatitis Coinfection Workshop; June 19–21, 2008; Madrid, Spain

Article • HIV Clinical Trials, February 2009, Taylor & Francis

Dr. Vicente Soriano
Prevalence of HLA-B*5701 in HIV-Infected Patients in Spain (Results of the EPI Study)

Article • HIV Clinical Trials, February 2009, Taylor & Francis

Dr. Vicente Soriano
New Therapies for Hepatitis C Virus Infection

Article • Clinical Infectious Diseases, February 2009, Oxford University Press (OUP)

Dr. Vicente Soriano
Raltegravir and Etravirine Are Active against HIV Type 1 Group O

Article • AIDS Research and Human Retroviruses, February 2009, Mary Ann Liebert Inc

Dr. Vicente Soriano
Non-covalent functionalization of carbon nanotubes with glycolipids: glyconanomaterials with specific lectin-affinity

Article • Soft Matter, January 2009, Royal Society of Chemistry

Dr. Vicente Soriano, Mohyeddin Assali
Clinical Differences and Viral Diversity between Newly HIV Type 1-Diagnosed African and Non-African Patients in Spain (2005–2007)

Article • AIDS Research and Human Retroviruses, January 2009, Mary Ann Liebert Inc

Dr. Vicente Soriano
Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program

Article • Enfermedades Infecciosas y Microbiología Clínica, January 2009, Elsevier

Dr. Vicente Soriano
Injecting, Sexual Risk Behaviors and HIV Infection in Young Cocaine and Heroin Users in Spain

Article • European Addiction Research, January 2009, Karger Publishers

Dr. Vicente Soriano
Level, phenotype and activation status of CD4+FoxP3+regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus

Article • Clinical & Experimental Immunology, January 2009, Wiley

Dr. Vicente Soriano
Predictors of severe hepatic steatosis using abdominal ultrasound in HIV-infected patients

Article • HIV Medicine, January 2009, Wiley

Dr. Vicente Soriano
Opportunistic Disease and Mortality in Patients Coinfected with Hepatitis B or C Virus in the Strategic Management of Antiretroviral Therapy (SMART) Study

Article • Clinical Infectious Diseases, December 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Editorial Commentary:Risks and Benefits of Using Antiretroviral Therapy in HIV‐Infected Patients with Chronic Hepatitis B in Developing Regions

Article • Clinical Infectious Diseases, December 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Upper Gastrointestinal Bleeding May Unmask Didanosine-Associated Portal Hepatopathy in HIV/HCV Co-infected Patients

Article • HIV Clinical Trials, December 2008, Taylor & Francis

Dr. Vicente Soriano
Resistencia viral y barrera genética de atazanavir

Article • Enfermedades Infecciosas y Microbiología Clínica, December 2008, Elsevier

Dr. Vicente Soriano
Detergent resistant membrane-associated IDE in brain tissue and cultured cells: Relevance to Aβ and insulin degradation

Article • Molecular Neurodegeneration, December 2008, Springer Science + Business Media

Dr. Vicente Soriano
Down‐Regulation of Interleukin‐7 Receptor (CD127) in HIV Infection Is Associated with T Cell Activation and Is a Main Factor Influencing Restoration of CD4+Cells after Antiretroviral Therapy

Article • The Journal of Infectious Diseases, November 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Recently acquired HIV infection in Spain (2003-2005): introduction of the serological testing algorithm for recent HIV seroconversion

Article • Sexually Transmitted Infections, November 2008, BMJ

Dr Jesus Almeda, Dr. Vicente Soriano
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?

Article • AIDS, November 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

Article • AIDS, November 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Diagnóstico de las infecciones por subtipos no B del VIH-1 y por VIH-2

Article • Enfermedades Infecciosas y Microbiología Clínica, November 2008, Elsevier

Dr. Vicente Soriano
Optimal use of maraviroc in clinical practice

Article • AIDS, November 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues

Article • AIDS, November 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin

Article • AIDS, November 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Resistencia a los inhibidores de la integrasa

Article • Enfermedades Infecciosas y Microbiología Clínica, November 2008, Elsevier

Dr. Vicente Soriano
Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in HIV‐Infected Patients with Anti‐HCV Antibodies in Europe

Article • The Journal of Infectious Diseases, November 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Reliability of Rapid Subtyping Tools Compared to That of Phylogenetic Analysis for Characterization of Human Immunodeficiency Virus Type 1 Non-B Subtypes and Recombinant Forms

Article • Journal of Clinical Microbiology, October 2008, ASM Journals

Dr. Vicente Soriano
Current trends in screening across ethnicities for hypersensitivity to abacavir

Article • Pharmacogenomics, October 2008, Future Medicine

Dr. Vicente Soriano
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

Article • AIDS, October 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Low Rate of Adverse Hepatic Events Associated with Fosamprenavir/Ritonavir-Based Antiretroviral Regimens

Article • HIV Clinical Trials, October 2008, Taylor & Francis

Dr. Vicente Soriano
Maraviroc: farmacocinética, interacciones y mecanismo de acción

Article • Enfermedades Infecciosas y Microbiología Clínica, October 2008, Elsevier

Dr. Vicente Soriano
Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4

Article • Journal of Viral Hepatitis, October 2008, Wiley

Dr. Vicente Soriano
Statements from the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), Toulon, France, May 28–30, 2008

Article • HIV Clinical Trials, October 2008, Taylor & Francis

Dr. Vicente Soriano
Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C

Article • Journal of Antimicrobial Chemotherapy, September 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone

Article • Journal of Antimicrobial Chemotherapy, September 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Usefulness of monitoring ribavirin plasma concentrations to improve treatment response in patients with chronic hepatitis C

Article • Journal of Antimicrobial Chemotherapy, September 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy

Article • AIDS, September 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Short Communication: HIV Rebound after Discontinuation of Antiretroviral Therapy Increases and Expands HIV-Specific CD8+ Responses But Has No Impact on Its Functionality

Article • AIDS Research and Human Retroviruses, September 2008, Mary Ann Liebert Inc

Dr. Vicente Soriano
No Major Differences in the Functional Profile of HIV Gag and Nef-Specific CD8+ Reponses between Long-Term Nonprogressors and Typical Progressors

Article • AIDS Research and Human Retroviruses, September 2008, Mary Ann Liebert Inc

Dr. Vicente Soriano
Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients

Article • Journal of Hepatology, September 2008, Elsevier

Dr. Vicente Soriano
Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 2008, New England Journal of Medicine (NEJM/MMS)

Dr. Vicente Soriano
Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 2008, New England Journal of Medicine (NEJM/MMS)

Dr. Vicente Soriano
Performance of Three Commercial Viral Load Assays, Versant Human Immunodeficiency Virus Type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, Testing HIV-1 Non-B Subtypes and Recombinant Variants

Article • Journal of Clinical Microbiology, July 2008, ASM Journals

Dr. Vicente Soriano
Increase of Non-B Subtypes and Recombinants Among Newly Diagnosed HIV-1 Native Spaniards and Immigrants in Spain

Article • Current HIV Research, July 2008, Bentham Science Publishers

Dr. Vicente Soriano
Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel

Article • AIDS, July 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain

Article • Blood Coagulation & Fibrinolysis, July 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Hepatitis C Virus Coinfection Does Not Affect CD4 Restoration in HIV-Infected Patients after Initiation of Antiretroviral Therapy

Article • AIDS Research and Human Retroviruses, July 2008, Mary Ann Liebert Inc

Dr. Vicente Soriano
Impact of antiretroviral therapy on chemokine (C-C motif) receptor 5 expression in HIV patients followed for over 2 years

Article • AIDS, July 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Management of Chronic Hepatitis C Virus Infection in HIV‐Infected Patients

Article • Clinical Infectious Diseases, July 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Performance of a Population-Based HIV-1 Tropism Phenotypic Assay and Correlation With V3 Genotypic Prediction Tools in Recent HIV-1 Seroconverters

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, July 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements

Article • Journal of Antimicrobial Chemotherapy, June 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Hepatitis B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to adefovir

Article • Journal of Antimicrobial Chemotherapy, June 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Changing Patterns in HIV Reverse Transcriptase Resistance Mutations after Availability of Tenofovir

Article • Clinical Infectious Diseases, June 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Hepatitis B vaccination: An unmet challenge in the era of harm reduction programs

Article • Journal of Substance Abuse Treatment, June 2008, Elsevier

Dr. Vicente Soriano
Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy

Article • Journal of Viral Hepatitis, June 2008, Wiley

Dr. Vicente Soriano
Papel de tenofovir en la coinfección por el virus de la inmunodeficiencia humana y el virus de la hepatitis C

Article • Enfermedades Infecciosas y Microbiología Clínica, June 2008, Elsevier

Dr. Vicente Soriano
Switch from Ritonavir-Boosted to Unboosted Atazanavir Guided by Therapeutic Drug Monitoring

Article • AIDS Research and Human Retroviruses, June 2008, Mary Ann Liebert Inc

Dr. Vicente Soriano
Incidence of anaemia and impact on sustained virological response in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin

Article • Journal of Viral Hepatitis, May 2008, Wiley

Dr Victor Asensi, Dr. Vicente Soriano
Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B

Article • Journal of Viral Hepatitis, May 2008, Wiley

Dr. Vicente Soriano
Presentación

Article • Enfermedades Infecciosas y Microbiología Clínica, May 2008, Elsevier

Dr. Vicente Soriano
Management of hepatitis B virus co-infection on and off antiretroviral therapy

Article • Current HIV/AIDS Reports, May 2008, Springer Science + Business Media

Dr. Vicente Soriano
Profile of Patients Triply Infected with HIV and the Hepatitis B and C Viruses in the HAART Era

Article • AIDS Research and Human Retroviruses, May 2008, Mary Ann Liebert Inc

Dr. Vicente Soriano, Victor Sanchez Margalet
Resistencias en el virus de la hepatitis B

Article • Enfermedades Infecciosas y Microbiología Clínica, May 2008, Elsevier

Dr. Vicente Soriano
Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8+ T cells

Article • European Journal of Immunology, April 2008, Wiley

Dr. Vicente Soriano
A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1

Article • AIDS, April 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?

Article • Journal of Antimicrobial Chemotherapy, April 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Changes Over Time in Risk Factors for Cardiovascular Disease and Use of Lipid‐Lowering Drugs in HIV‐Infected Individuals and Impact on Myocardial Infarction

Article • Clinical Infectious Diseases, April 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Short Communication: Association between Tipranavir Plasma Levels and Virological Response in HIV-Infected Patients

Article • AIDS Research and Human Retroviruses, March 2008, Mary Ann Liebert Inc

Dr. Vicente Soriano
Emerging drugs for hepatitis C

Article • Expert Opinion on Emerging Drugs, March 2008, Informa Healthcare

Dr. Vicente Soriano
Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes

Article • AIDS, March 2008, Wolters Kluwer Health

Dr. Vicente Soriano
HIV-1 Infection in Persistently HIV-1-Seronegative Individuals: More Reasons for HIV RNA Screening

Article • Clinical Infectious Diseases, March 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Lobeline attenuates progressive ratio breakpoint scores for intracranial self-stimulation in rats

Article • Physiology & Behavior, March 2008, Elsevier

Dr. Vicente Soriano
Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome

Article • Journal of Antimicrobial Chemotherapy, February 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Hepatitis B virus escape mutants induced by antiviral therapy

Article • Journal of Antimicrobial Chemotherapy, February 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola

Article • Journal of Antimicrobial Chemotherapy, February 2008, Oxford University Press (OUP)

Dr. Vicente Soriano
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults

Article • HIV Medicine, February 2008, Wiley

Dr. Vicente Soriano
The implications of antiviral drugs with activity against hepatitis B virus and HIV

Article • Current Opinion in Internal Medicine, February 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Evaluation of Eight Different Bioinformatics Tools To Predict Viral Tropism in Different Human Immunodeficiency Virus Type 1 Subtypes

Article • Journal of Clinical Microbiology, January 2008, ASM Journals

Dr. Vicente Soriano
Antiretroviral drugs and liver injury

Article • AIDS, January 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA

Article • AIDS, January 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools

Article • Journal of Medical Virology, January 2008, Wiley

Dr. Vicente Soriano
Initial spontaneous clearance and re-infection with a distinct hepatitis C virus genotype leading to chronic hepatitis C in an HIV+ intravenous drug user

Article • AIDS, January 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance

Article • AIDS, January 2008, Wolters Kluwer Health

Dr. Vicente Soriano
Prevalence of and Risk Factors for Hepatitis B Virus Infection among Street-Recruited Young Injection and Non-Injection Heroin Users in Barcelona, Madrid and Seville

Article • European Addiction Research, January 2008, Karger Publishers

Dr. Vicente Soriano
Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C

Article • AIDS, January 2008, Wolters Kluwer Health

Dr. Vicente Soriano
698 NUCLEOS(T)IDE ANALOGUE TREATMENT FOR HBV INFECTIONS CAN RESULT IN THE SELECTION OF POSSIBLE HBV VACCINE ESCAPE MUTANTS

Article • Journal of Hepatology, January 2008, Elsevier

Dr. Vicente Soriano
770 HCV RELAPSES UPON COMPLETION OF PEG-INTERFERON PLUS RIBAVIRIN IN HIV-INFECTED PATIENTS: RATE, TIMING AND PREDICTORS

Article • Journal of Hepatology, January 2008, Elsevier

Dr. Vicente Soriano
801 RESCUE THERAPY WITH OPTIMIZED PEG-INTERFERON PLUS RIBAVIRIN IN HIV/HCV COINFECTED PATIENTS: CRITICAL ROLE OF RIBAVIRIN PLASMA LEVELS IN THE PILOT-NR TRIAL

Article • Journal of Hepatology, January 2008, Elsevier

Dr. Vicente Soriano
838 DISTINCT HEPATITIS C VIRUS KINETICS IN HIV+ PATIENTS TREATED WITH RIBAVIRIN PLUS EITHER PEGYLATED INTERFERON ALFA-2A OR ALFA-2B

Article • Journal of Hepatology, January 2008, Elsevier

Dr. Vicente Soriano
708 POLYMORPHISMS WHICH MAY BE RESPONSIBLE FOR PRIMARY TREATMENT FAILURE TO ADEFOVIR IN DISTINCT HEPATITIS B VIRUS GENOTYPES

Article • Journal of Hepatology, January 2008, Elsevier

Dr. Vicente Soriano
606 RELATIONSHIP BETWEEN THE STAGE OF LIVER FIBROSIS AND REGULATORY T (TREG) CELLS IN PATIENTS WITH CHRONIC HEPATITIS C COINFECTED WITH HIV

Article • Journal of Hepatology, January 2008, Elsevier

Dr. Vicente Soriano
The changing epidemiology of hepatitis C virus infection in Europe

Article • Journal of Hepatology, January 2008, Elsevier

Dr. Vicente Soriano
Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years

Article • Journal of Antimicrobial Chemotherapy, December 2007, Oxford University Press (OUP)

Dr. Vicente Soriano
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2007, Wolters Kluwer Health

Dr Maria Rosaria Capobianchi, Dr. Vicente Soriano
Measurement of Ribavirin Plasma Concentrations by High-performance Liquid Chromatography Using a Novel Solid-phase Extraction Method in Patients Treated for Chronic Hepatitis C

Article • Therapeutic Drug Monitoring, December 2007, Wolters Kluwer Health

Dr. Vicente Soriano
Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial

Article • Journal of Antimicrobial Chemotherapy, November 2007, Oxford University Press (OUP)

Dr. Vicente Soriano
Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART

Article • AIDS, November 2007, Wolters Kluwer Health

Dr. Vicente Soriano
Human T Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis in an HIV-Positive Patient Coinfected with Human T Lymphotropic Virus Type 2 Following Initiation of Antiretroviral Therapy

Article • Clinical Infectious Diseases, November 2007, Oxford University Press (OUP)

Dr. Vicente Soriano
Management and therapy of chronic hepatitis C in HIV

Article • Current Opinion in HIV and AIDS, November 2007, Wolters Kluwer Health

Dr. Vicente Soriano
Selection of Hepatitis B Virus (HBV) Vaccine Escape Mutants in HBV-Infected and HBV/HIV-Coinfected Patients Failing Antiretroviral Drugs With Anti-HBV Activity

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, November 2007, Wolters Kluwer Health

Dr. Vicente Soriano
Value of the HLA-B*5701 Allele to Predict Abacavir Hypersensitivity in Spaniards

Article • AIDS Research and Human Retroviruses, November 2007, Mary Ann Liebert Inc

Dr. Vicente Soriano
Linear IgA bullous dermatosis associated with systemic lupus erythematosus: a case report

Article • Clinical Rheumatology, October 2007, Springer Science + Business Media

Dr. Vicente Soriano
Impact of baseline protease genotype and phenotype on the response to darunavir outside clinical trials

Article • Journal of Antimicrobial Chemotherapy, October 2007, Oxford University Press (OUP)

Dr. Vicente Soriano
Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors

Article • Journal of Antimicrobial Chemotherapy, October 2007, Oxford University Press (OUP)

Dr. Vicente Soriano
Efficacy and Safety of a Once Daily Regimen with Efavirenz, Lamivudine, and Didanosine, with and without Food, as Initial Therapy for HIV Infection: The ELADI Study

Article • AIDS Research and Human Retroviruses, October 2007, Mary Ann Liebert Inc

Dr Victor Asensi, Dr. Vicente Soriano
Respuesta inmunitaria celular adaptativa frente a la infección por el virus de la hepatitis C

Article • Medicina Clínica, October 2007, Elsevier

Dr. Vicente Soriano
Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses

Article • AIDS, October 2007, Wolters Kluwer Health

Dr. Vicente Soriano
Large lymphadenopathies complicating the abacavir hypersensitivity reaction

Article • AIDS, October 2007, Wolters Kluwer Health

Dr. Vicente Soriano
Short Communication: Dynamics of Drug-Resistant HIV-1 in Plasma and Peripheral Blood Cells in Patients during and after Enfuvirtide Therapy

Article • AIDS Research and Human Retroviruses, September 2007, Mary Ann Liebert Inc

Dr Dimitrios Paraskevis, Dr. Vicente Soriano
Amino Acid Conservation in the gp41 Transmembrane Protein and Natural Polymorphisms Associated with Enfuvirtide Resistance across HIV-1 Variants

Article • AIDS Research and Human Retroviruses, September 2007, Mary Ann Liebert Inc

Dr. Vicente Soriano
Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV‐Infected Patients

Article • The Journal of Infectious Diseases, September 2007, Oxford University Press (OUP)

Dr. Vicente Soriano
Short Communication: Hospital-Based Surveillance for HTLV-1/2 Infections in Spain

Article • AIDS Research and Human Retroviruses, September 2007, Mary Ann Liebert Inc

Dr. Vicente Soriano, Enrique J. Calderon
Estavudina en el tratamiento antirretroviral

Article • Medicina Clínica, September 2007, Elsevier

Dr. Vicente Soriano
Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome

Article • Journal of Viral Hepatitis, August 2007, Wiley

Dr. Vicente Soriano
Churg-Strauss syndrome triggered by hyposensitization to Alternaria fungus

Article • Clinical Rheumatology, August 2007, Springer Science + Business Media

Dr. Vicente Soriano
Baseline Serum Hepatitis C Virus (HCV) RNA Level and Response at Week 4 Are the Best Predictors of Relapse After Treatment With Pegylated Interferon Plus Ribavirin in HIV/HCV-Coinfected Patients

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2007, Wolters Kluwer Health

Dr. Vicente Soriano
Role of Weight-Based Ribavirin Dosing and Extended Duration of Therapy in Chronic Hepatitis C in HIV-Infected Patients: The PRESCO Trial

Article • AIDS Research and Human Retroviruses, August 2007, Mary Ann Liebert Inc

Dr Victor Asensi, Dr. Vicente Soriano
Escape Mutations in HIV Infection and its Impact on CD8+ T Cell Responses

Article • Current Molecular Medicine, August 2007, Bentham Science Publishers

Dr. Vicente Soriano
Authors?? Reply to ???How Safe Is Unprotected Sex Between Discordant Couples to Conceive in the Highly Active Antiretroviral Therapy Era????

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2007, Wolters Kluwer Health

Dr. Vicente Soriano
Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection

Article • Expert Opinion on Investigational Drugs, August 2007, Informa Healthcare

Dr. Vicente Soriano
Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors

Article • Journal of Antimicrobial Chemotherapy, July 2007, Oxford University Press (OUP)

Dr. Vicente Soriano
Changing Rates and Patterns of Drug Resistance Mutations in Antiretroviral-Experienced HIV-Infected Patients

Article • AIDS Research and Human Retroviruses, July 2007, Mary Ann Liebert Inc

Dr. Vicente Soriano
Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use

Article • AIDS, July 2007, Wolters Kluwer Health

Dr. Vicente Soriano
Impact of Ethnicity and HIV Type 1 Subtype on Response to First-Line Antiretroviral Therapy

Article • AIDS Research and Human Retroviruses, July 2007, Mary Ann Liebert Inc

Dr. Vicente Soriano
Is natural conception a valid option for HIV-serodiscordant couples?

Article • Human Reproduction, June 2007, Oxford University Press (OUP)

Dr. Vicente Soriano
Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

Article • BMC Infectious Diseases, June 2007, Springer Science + Business Media

Dr. Vicente Soriano
Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors

Article • Infection Genetics and Evolution, June 2007, Elsevier

Dr. Vicente Soriano
Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis

Article • Journal of Viral Hepatitis, June 2007, Wiley

Dr. Vicente Soriano
Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients

Article • Journal of Viral Hepatitis, June 2007, Wiley

Dr. Vicente Soriano
Infección por el virus de la inmunodeficiencia humana tipo 2 y virus linfotrópicos humanos tipos 1 y 2 en España

Article • Medicina Clínica, June 2007, Elsevier

Enrique J. Calderon, Dr. Vicente Soriano
Liver Fibrosis Stage and HCV Genotype Distribution in HIV–HCV Coinfected Patients with Persistently Normal Transaminases

Article • AIDS Research and Human Retroviruses, June 2007, Mary Ann Liebert Inc

Dr. Vicente Soriano
Consejo reproductivo en parejas serodiscordantes para el virus de la inmunodeficiencia humana

Article • Medicina Clínica, June 2007, Elsevier

Dr. Vicente Soriano
Hydroxyurea exerts an anti-proliferative effect on T cells but has no direct impact on cellular activation

Article • Clinical & Experimental Immunology, May 2007, Wiley

Dr. Vicente Soriano
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV–HIV International Panel

Article • AIDS, May 2007, Wolters Kluwer Health

Dr. Vicente Soriano
Telbivudine: a new option for the treatment of chronic hepatitis B

Article • Expert Opinion on Biological Therapy, May 2007, Informa Healthcare

Dr. Vicente Soriano
C2-Symmetric Bissulfoxides as Organocatalysts in the Allylation of Benzoyl Hydrazones: Spacer and Concentration Effects

Article • Organic Letters, May 2007, American Chemical Society (ACS)

Dr. Vicente Soriano
Evolution of T-cell Responses to Hepatitis C Virus (HCV) during Pegylated Interferon plus Ribavirin treatment in HCV-Monoinfected and in HCV/HIV-Coinfected Patients

Article • Antiviral Therapy, May 2007, SAGE Publications

Dr. Vicente Soriano
Treatment of Chronic Hepatitis B or C in HIV‐Infected Patients with Dual Viral Hepatitis

Article • The Journal of Infectious Diseases, April 2007, Oxford University Press (OUP)

Dr. Vicente Soriano
CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load

Article • Journal of Antimicrobial Chemotherapy, April 2007, Oxford University Press (OUP)

Dr. Vicente Soriano, annalisa de silvestri
Hepatitis B Virus Genotypes and Lamivudine Resistance Mutations in HIV/Hepatitis B Virus-Coinfected Patients

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2007, Wolters Kluwer Health

Dr. Vicente Soriano
[591] IMPACT OF ANEMIA AND ZIDOVUDINE USE ON SUSTAINED VIROLOGICAL RESPONSE IN A TRIAL OF PEGYLATED INTERFERON PLUS RIBAVIRIN IN HIV/HCV-COINFECTED PATIENTS

Article • Journal of Hepatology, April 2007, Elsevier

Dr Victor Asensi, Dr. Vicente Soriano
Evaluation of performance across the dynamic range of the Abbott RealTime™ HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses

Article • Journal of Virological Methods, April 2007, Elsevier

Dr. Vicente Soriano
Influence of Liver Fibrosis Stage on Plasma Levels of Antiretroviral Drugs in HIV‐Infected Patients with Chronic Hepatitis C

Article • The Journal of Infectious Diseases, April 2007, Oxford University Press (OUP)

Dr. Vicente Soriano
Introduction of Non-B Subtypes among Spaniards Newly Diagnosed with HIV Type 1 in the Canary Islands

Article • AIDS Research and Human Retroviruses, April 2007, Mary Ann Liebert Inc

Dr. Vicente Soriano
Outbreak of Syphilis, but Not of Acute Hepatitis C, Among HIV-Infected Homosexual Men in Madrid

Article • HIV Clinical Trials, April 2007, Taylor & Francis

Dr. Vicente Soriano
Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients

Article • Expert Opinion on Pharmacotherapy, April 2007, Informa Healthcare

Dr. Vicente Soriano
[188] INFLUENCE OF ANTIRETROVIRALS IN THE PROGRESSION OF LIVER FIBROSIS IN HIV/HCV COINFECTED PATIENT S. EFFECT OF HEPATOTOXICITY AND METABOLIC ABNORMALITIES

Article • Journal of Hepatology, April 2007, Elsevier

Dr. Vicente Soriano
[512] HEPATITIS B VIRUS MUTANTS IN PATIENTS FAILING ANTIRETROVIRALS WITH ANTI-HBV ACTIVITY: IMPLICATIONS FOR DIAGNOSTICS AND VACCINE ESCAPE

Article • Journal of Hepatology, April 2007, Elsevier

Dr. Vicente Soriano
[616] BASELINE HCVRNA AND RAPID VIROLOGICAL DECAY ARE THE MAIN PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE IN HIV-HCV COINFECTED PATIENTS

Article • Journal of Hepatology, April 2007, Elsevier

Dr. Vicente Soriano
[697] LIVER FIBROSIS IN HIV-INFECTED PATIENTS WITHOUT CHRONIC VIRAL HEPATITIS. PREVALENCE, CLINICAL CHARACTERISTICS AND POTENTIAL CAUSES

Article • Journal of Hepatology, April 2007, Elsevier

Dr. Vicente Soriano
Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment

Article • Expert Opinion on Pharmacotherapy, March 2007, Informa Healthcare

Dr. Vicente Soriano
Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy

Article • AIDS, March 2007, Wolters Kluwer Health

Dr. Vicente Soriano
Prevalence and therapeutic significance of anti-interferon antibodies in hepatitis C virus/HIV-co-infected patients

Article • AIDS, March 2007, Wolters Kluwer Health

Dr. Vicente Soriano
P1899 Assessment of liver cirrhosis by elastography in HCV/HIV co–infected patients

Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

Dr. Vicente Soriano
Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance

Article • Journal of Antimicrobial Chemotherapy, February 2007, Oxford University Press (OUP)

Dr. Vicente Soriano
Recomendaciones españolas sobre el uso adecuado de enfuvirtida

Article • Enfermedades Infecciosas y Microbiología Clínica, February 2007, Elsevier

Dr. Vicente Soriano
Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: Implications for HCV therapy in HCV/HIV-coinfected patients

Article • Journal of Infection, February 2007, Elsevier

Dr. Vicente Soriano
Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma

Article • European Journal of Immunology, February 2007, Wiley

Dr. Vicente Soriano
Susceptibility of HIV-1 non-B subtypes and recombinant variants to Enfuvirtide

Article • Journal of Clinical Virology, February 2007, Elsevier

Dr. Vicente Soriano
Adult neurogenesis and schizophrenia: A window on abnormal early brain development?

Article • Schizophrenia Research, February 2007, Elsevier

Dr. Vicente Soriano
Drug Interactions of Tipranavir, a New HIV Protease Inhibitor

Article • Drug Metabolism Letters, January 2007, Bentham Science Publishers

Dr. Vicente Soriano
Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia

Article • AIDS, January 2007, Wolters Kluwer Health

Dr. Vicente Soriano
Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4+ and CD8+ T-cell responses to hepatitis C virus

Article • Journal of Medical Virology, January 2007, Wiley

Dr. Vicente Soriano
Influence of Human T Cell Lymphotropic Virus Type 2 Coinfection on Virological and Immunological Parameters in HIV Type 1–Infected Patients

Article • Clinical Infectious Diseases, January 2007, Oxford University Press (OUP)

Dr. Vicente Soriano
Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy “don’t ask, draw a blood sample, vaccinate and try to schedule another visit”

Article • Journal of Clinical Virology, January 2007, Elsevier

Dr. Vicente Soriano
Prevalence of X4 tropic HIV-1 variants in patients with differences in disease stage and exposure to antiretroviral therapy

Article • Journal of Medical Virology, January 2007, Wiley

Dr. Vicente Soriano
Cohorte RIS de pacientes con infección por VIH sin tratamiento antirretroviral previo (CoRIS): metodología y primeros resultados

Article • Enfermedades Infecciosas y Microbiología Clínica, January 2007, Elsevier

Dr. Vicente Soriano
Aplicación de modelos estructurales marginales para estimar los efectos de la terapia antirretroviral en 5 cohortes de seroconvertores al virus de la inmunodeficiencia humana

Article • Gaceta Sanitaria, January 2007, Elsevier

Dr. Vicente Soriano
Genetic analysis of the long terminal repeat (LTR) promoter region in HIV-1-infected individuals with different rates of disease progression

Article • Virus Genes, December 2006, Springer Science + Business Media

Dr. Vicente Soriano
Rate of Virologic Failure and Selection of Drug Resistance Mutations Using Different Triple Nucleos(t)ide Analogue Combinations in HIV-Infected Patients

Article • AIDS Research and Human Retroviruses, December 2006, Mary Ann Liebert Inc

Dr. Vicente Soriano
Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002

Article • Journal of Viral Hepatitis, December 2006, Wiley

Dr. Vicente Soriano
Quantitative Detection of Plasma Human Immunodeficiency Virus Type 2 Subtype A RNA by the Nuclisens EasyQ Assay (Version 1.1)

Article • Journal of Clinical Microbiology, November 2006, ASM Journals

Dr. Vicente Soriano
Natural Pregnancies in HIV-Serodiscordant Couples Receiving Successful Antiretroviral Therapy

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, November 2006, Wolters Kluwer Health

Dr. Vicente Soriano
Coinfection with Hepatitis C Virus Increases Lymphocyte Apoptosis in HIV-Infected Patients

Article • Clinical Infectious Diseases, November 2006, Oxford University Press (OUP)

Dr. Vicente Soriano
Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin

Article • AIDS, November 2006, Wolters Kluwer Health

Dr. Vicente Soriano
Chemoprophylaxis with Tenofovir Disoproxil Fumarate Provided Partial Protection against Infection with Simian Human Immunodeficiency Virus in Macaques Given Multiple Virus Challenges

Article • The Journal of Infectious Diseases, October 2006, Oxford University Press (OUP)

Dr. Vicente Soriano
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection

Article • AIDS, October 2006, Wolters Kluwer Health

Dr. Vicente Soriano
Implicaciones diagnósticas, clínicas y terapéuticas de las hepatitis virales en el paciente infectado por el VIH

Article • Enfermedades Infecciosas y Microbiología Clínica, October 2006, Elsevier

Dr. Vicente Soriano
Infecciones por VIH-2 y HTLV-1/2 en España

Article • Enfermedades Infecciosas y Microbiología Clínica, October 2006, Elsevier

Dr. Vicente Soriano
Tratamiento de la hepatitis crónica B en pacientes infectados por el VIH

Article • Gastroenterología y Hepatología, October 2006, Elsevier

Dr. Vicente Soriano
Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis B Extensively Exposed to Antiretroviral Therapy with Anti-HBV Activity

Article • HIV Clinical Trials, October 2006, Taylor & Francis

Dr. Vicente Soriano
Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors

Article • Epidemiology and Infection, September 2006, Cambridge University Press

Dr. Vicente Soriano
Impact of Antiretroviral Treatment-Related Toxicities on Hospital Admissions in HIV-Infected Patients

Article • AIDS Research and Human Retroviruses, September 2006, Mary Ann Liebert Inc

Dr. Vicente Soriano
Impact of Gag Sequence Variability on Level, Phenotype, and Function of Anti-HIV Gag-Specific CD8+ Cytotoxic T Lymphocytes in Untreated Chronically HIV-Infected Patients

Article • AIDS Research and Human Retroviruses, September 2006, Mary Ann Liebert Inc

Dr. Vicente Soriano
¿Se debería recomendar el cribado de la infección por el virus linfotrópico humano de células T de tipo 1 en las mujeres embarazadas?

Article • Progresos de Obstetricia y Ginecología, September 2006, Sociedad Espanola de Nutricion Parenteral y Enteral (SENPE)

Dr. Vicente Soriano
Virological Outcome of Chronic Hepatitis B Virus Infection in HIV-Coinfected Patients Receiving Anti-HBV Active Antiretroviral Therapy

Article • AIDS Research and Human Retroviruses, September 2006, Mary Ann Liebert Inc

Dr. Vicente Soriano
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus

Article • Archives of Internal Medicine, August 2006, American Medical Association (AMA)

Dr. Vicente Soriano
Immunological and Virological Effects of Structured Treatment Interruptions following Exposure to Hydroxyurea Plus Didanosine

Article • AIDS Research and Human Retroviruses, August 2006, Mary Ann Liebert Inc

Dr. Vicente Soriano
Natural polymorphisms in the protease gene modulate the replicative capacity of non-B HIV-1 variants in the absence of drug pressure

Article • Journal of Clinical Virology, August 2006, Elsevier

Dr. Vicente Soriano
Performance of Six Different Ritonavir-Boosted Protease Inhibitor–Based Regimens in Heavily Antiretroviral-Experienced HIV-Infected Patients

Article • HIV Clinical Trials, August 2006, Taylor & Francis

Dr. Vicente Soriano
Mutations affecting the replication capacity of the hepatitis B virus

Article • Journal of Viral Hepatitis, July 2006, Wiley

Dr. Vicente Soriano
Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors

Article • AIDS, July 2006, Wolters Kluwer Health

Dr. Vicente Soriano
Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, June 2006, Wolters Kluwer Health

Dr. Vicente Soriano
HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors

Article • AIDS, June 2006, Wolters Kluwer Health

Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu
Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes

Article • Journal of Epidemiology & Community Health, June 2006, BMJ

Dr. Vicente Soriano
Seroreversion of HIV antibodies in patients with prolonged suppression of viraemia under HAART

Article • AIDS, June 2006, Wolters Kluwer Health

Dr. Vicente Soriano
Coinfección por el VIH y el virus de la hepatitis C

Article • Enfermedades Infecciosas y Microbiología Clínica, May 2006, Elsevier

Dr. Vicente Soriano
Management of chronic hepatitis B and C in HIV-coinfected patients

Article • Journal of Antimicrobial Chemotherapy, May 2006, Oxford University Press (OUP)

Dr. Vicente Soriano
External Validation of Atazanavir/Ritonavir Genotypic Score in HIV-1 Protease Inhibitor-Experienced Patients

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, May 2006, Wolters Kluwer Health

Dr. Vicente Soriano
Higher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus Tenofovir

Article • AIDS Research and Human Retroviruses, April 2006, Mary Ann Liebert Inc

Dr. Vicente Soriano
Predictors of Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis C Virus (HCV) Infection: Assessment Using Transient Elastometry and the Role of HCV Genotype 3

Article • Clinical Infectious Diseases, April 2006, Oxford University Press (OUP)

Dr. Vicente Soriano
Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance

Article • AIDS, April 2006, Wolters Kluwer Health

Dr. Vicente Soriano
574 Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients

Article • Journal of Hepatology, April 2006, Elsevier

Dr. Vicente Soriano
421 Hepatitis C virus (HCV)-specific CD4+ and CD8+ T cell responses in patients with chronic hepatitis C treated with pegylated interferon plus ribavirin

Article • Journal of Hepatology, April 2006, Elsevier

Dr. Vicente Soriano
Suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir

Article • Journal of Antimicrobial Chemotherapy, March 2006, Oxford University Press (OUP)

Dr. Vicente Soriano
The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, March 2006, Wolters Kluwer Health

Dr. Vicente Soriano
Chronic Hepatitis C in HIV-Infected Patients: Those Who More Need Therapy are Those Who Respond Less

Article • Infectious Disorders - Drug Targets, March 2006, Bentham Science Publishers

Dr. Vicente Soriano
Entrada del virus de la inmunodeficiencia humana en las células: mecanismos y posibilidades terapéuticas

Article • Medicina Clínica, March 2006, Elsevier

Dr. Vicente Soriano
HTLV infection among young injection and non-injection heroin users in Spain: Prevalence and correlates

Article • Journal of Clinical Virology, March 2006, Elsevier

Dr. Vicente Soriano
Standard of Care for HCV/HIV-Coinfected Patients

Article • Journal of Chemotherapy, March 2006, Taylor & Francis

Dr. Vicente Soriano
HIV entry inhibitors: mechanisms of action and resistance pathways

Article • Journal of Antimicrobial Chemotherapy, February 2006, Oxford University Press (OUP)

Dr. Vicente Soriano
Overview of the pharmacogenetics of HIV therapy

Article • The Pharmacogenomics Journal, February 2006, Springer Science + Business Media

Dr. Vicente Soriano
Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy

Article • Journal of Antimicrobial Chemotherapy, February 2006, Oxford University Press (OUP)

Dr. Vicente Soriano
Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent

Article • Antimicrobial Agents and Chemotherapy, February 2006, ASM Journals

Dr. Vicente Soriano
Effectiveness and Safety of Abacavir, Lamivudine, and Zidovudine in Antiretroviral Therapy-Naive HIV-Infected Patients

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, February 2006, Wolters Kluwer Health

Dr. Vicente Soriano
Tratamiento antirretroviral en la infección por el virus de la inmunodeficiencia humana: ¿cuánto dura su eficacia?

Article • Medicina Clínica, February 2006, Elsevier

Dr. Vicente Soriano
Respuesta de los autores

Article • Medicina Clínica, February 2006, Elsevier

Dr. Vicente Soriano
Confronting chronic hepatitis B virus infection in HIV: new diagnostic tools and more weapons

Article • AIDS, February 2006, Wolters Kluwer Health

Dr. Vicente Soriano
Variability in the P6gag domains of HIV-1 involved in viral budding

Article • AIDS, February 2006, Wolters Kluwer Health

Dr. Vicente Soriano
Plasma Levels of Atazanavir and the Risk of Hyperbilirubinemia Are Predicted by the 3435C->T Polymorphism at the Multidrug Resistance Gene 1

Article • Clinical Infectious Diseases, January 2006, Oxford University Press (OUP)

Dr. Vicente Soriano
High rate of proV47A selection in HIV-2 patients failing lopinavir-based HAART

Article • AIDS, January 2006, Wolters Kluwer Health

Dr. Vicente Soriano
Can the Level of Immunosuppression in Human Immunodeficiency Virus-Infected Patients Affect the Reliability of Human T-Cell Lymphotropic Virus Type 2 Serological Diagnosis?

Article • Clinical and Vaccine Immunology, January 2006, ASM Journals

Dr. Vicente Soriano
Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain

Article • Journal of Medical Virology, January 2006, Wiley

Dr. Vicente Soriano
Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C

Article • Scandinavian Journal of Infectious Diseases, January 2006, Taylor & Francis

Dr. Vicente Soriano
Treatment of chronic hepatitis C in HIV-positive individuals: Selection of candidates

Article • Journal of Hepatology, January 2006, Elsevier

Dr. Vicente Soriano
Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis B Extensively Exposed to Antiretroviral Therapy with Anti-HBV Activity

Article • HIV Clinical Trials, January 2006, Taylor & Francis

Dr. Vicente Soriano
CD4+T Cell Recovery beyond the First Year of Complete Suppression of Viral Replication during Highly Active Antiretroviral Therapy Is Not Influenced by CD8+T Cell Activation

Article • The Journal of Infectious Diseases, December 2005, Oxford University Press (OUP)

Dr. Vicente Soriano
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?

Article • AIDS, December 2005, Wolters Kluwer Health

Dr. Vicente Soriano
Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapy

Article • Journal of Clinical Virology, December 2005, Elsevier

Dr. Vicente Soriano
Characteristics and Prospects for Hepatitis C Therapy of an HIV-HCV Coinfected Population Followed at a Reference HIV Center

Article • HIV Clinical Trials, December 2005, Taylor & Francis

Dr. Vicente Soriano
Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America

Article • Clinical Infectious Diseases, December 2005, Oxford University Press (OUP)

Dr. Vicente Soriano
NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder

Article • Schizophrenia Research, December 2005, Elsevier

Dr. Vicente Soriano
New paradigms in the management of HIV and hepatitis C virus coinfection

Article • Current Opinion in Infectious Diseases, December 2005, Wolters Kluwer Health

Dr. Vicente Soriano
Phage Display Selection of HIV Specific Conserved Mimotopes With IgG from Long-term Non-progressors

Article • Retrovirology, December 2005, Springer Science + Business Media

Dr. Vicente Soriano
Complications in treating chronic hepatitis B in patients with HIV

Article • Expert Opinion on Pharmacotherapy, November 2005, Informa Healthcare

Dr. Vicente Soriano
Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir

Article • AIDS, November 2005, Wolters Kluwer Health

Dr. Vicente Soriano
Genetic Analysis of Regulatory, Promoter, and TAR Regions of LTR Sequences Belonging to HIV Type 1 Non-B Subtypes

Article • AIDS Research and Human Retroviruses, November 2005, Mary Ann Liebert Inc

Dr. Vicente Soriano
Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors and Prevalence of HIV Type 1 Non-B Subtypes Are Increasing among Persons with Recent Infection in Spain

Article • Clinical Infectious Diseases, November 2005, Oxford University Press (OUP)

Dr. Vicente Soriano
Effect of Ribavirin on Intracellular and Plasma Pharmacokinetics of Nucleoside Reverse Transcriptase Inhibitors in Patients with Human Immunodeficiency Virus-Hepatitis C Virus Coinfection: Results of a Randomized Clinical Study

Article • Antimicrobial Agents and Chemotherapy, October 2005, ASM Journals

Dr. Vicente Soriano
Differences in the Length of Gag Proteins among Different HIV Type 1 Subtypes

Article • AIDS Research and Human Retroviruses, October 2005, Mary Ann Liebert Inc

Dr. Vicente Soriano
Failure of Hepatitis C Therapy in HIV‐Coinfected Drug Users Is Not Due to a Shift in Hepatitis C Virus Genotype

Article • The Journal of Infectious Diseases, October 2005, Oxford University Press (OUP)

Dr. Vicente Soriano
Hepatic and Renal Safety Profile of Tenofovir in HIV-Infected Patients with Hepatitis C, Including Patients on Interferon Plus Ribavirin

Article • HIV Clinical Trials, October 2005, Taylor & Francis

Dr. Vicente Soriano
Sustained Virological Response following HCV Therapy is Associated with Non-Progression of Liver Fibrosis in HCV/HIV-Coinfected Patients

Article • Antiviral Therapy, October 2005, SAGE Publications

Dr. Vicente Soriano
Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

Article • The Journal of Infectious Diseases, September 2005, Oxford University Press (OUP)

Dr. Vicente Soriano
Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy

Article • The Journal of Infectious Diseases, September 2005, Oxford University Press (OUP)

Dr. Vicente Soriano
Superiority of Protease Inhibitors over Nonnucleoside Reverse-Transcriptase Inhibitors when Highly Active Antiretroviral Therapy Is Resumed after Treatment Interruption

Article • Clinical Infectious Diseases, September 2005, Oxford University Press (OUP)

Dr. Vicente Soriano
Addressing current challenges in haemophilia care: consensus recommendations of a European Interdisciplinary Working Group

Article • Haemophilia, September 2005, Wiley

Dr. Vicente Soriano
Clinical benefit of interventions driven by therapeutic drug monitoring

Article • HIV Medicine, September 2005, Wiley

Dr. Vicente Soriano
HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003

Article • HIV Medicine, September 2005, Wiley

Dr. Vicente Soriano
Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection

Article • AIDS Research and Human Retroviruses, September 2005, Mary Ann Liebert Inc

Dr. Vicente Soriano
Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Genetic Diversity on Performance of Four Commercial Viral Load Assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT

Article • Journal of Clinical Microbiology, August 2005, ASM Journals

Dr. Vicente Soriano
Early Monitoring of Ribavirin Plasma Concentrations May Predict Anemia and Early Virologic Response in HIV/Hepatitis C Virus-Coinfected Patients

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2005, Wolters Kluwer Health

Dr. Vicente Soriano
Reductions in Stavudine Dose Might Ameliorate Mitochondrial-Associated Complications Without Compromising Antiviral Activity

Article • HIV Clinical Trials, August 2005, Taylor & Francis

Dr. Vicente Soriano
Antiretroviral Recommendations May Influence the Rate of Transmission of Drug‐Resistant HIV Type 1

Article • Clinical Infectious Diseases, July 2005, Oxford University Press (OUP)

Dr. Vicente Soriano
Viral Response to Antiretroviral Therapy in a Patient Coinfected with HIV Type 1 and Type 2

Article • Clinical Infectious Diseases, July 2005, Oxford University Press (OUP)

Dr. Vicente Soriano
Erratum

Article • The Lancet Infectious Diseases, July 2005, Elsevier

Dr. Vicente Soriano
Liver Transplantation in HIV–HCV Coinfected Candidates: What Is the Most Appropriate Time for Evaluation?

Article • AIDS Research and Human Retroviruses, July 2005, Mary Ann Liebert Inc

Dr. Vicente Soriano
Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma

Article • Journal of Virological Methods, July 2005, Elsevier

Dr. Vicente Soriano
Treatment Response and Drug Resistance in Patients Infected with HIV Type 1 Group O Viruses

Article • AIDS Research and Human Retroviruses, July 2005, Mary Ann Liebert Inc

Dr. Vicente Soriano
Short Communication: Changes in Nevirapine Plasma Concentrations Over Time and Its Relationship with Liver Enzyme Elevations

Article • AIDS Research and Human Retroviruses, June 2005, Mary Ann Liebert Inc

Dr. Vicente Soriano
Enfuvirtide Is Active against HIV Type 1 Group O

Article • AIDS Research and Human Retroviruses, June 2005, Mary Ann Liebert Inc

Dr. Vicente Soriano
Management of patients co-infected with hepatitis B virus and HIV

Article • The Lancet Infectious Diseases, June 2005, Elsevier

Dr. Vicente Soriano
Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping Due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection

Article • AIDS Research and Human Retroviruses, June 2005, Mary Ann Liebert Inc

Dr. Vicente Soriano
Outmoded Attitudes Toward Organ Donation Among Turkish Health Care Professionals

Article • Transplantation Proceedings, June 2005, Elsevier

Dr. Vicente Soriano
Influence of 516G>T Polymorphisms at the Gene Encoding the CYP450-2B6 Isoenzyme on Efavirenz Plasma Concentrations in HIV-Infected Subjects

Article • Clinical Infectious Diseases, May 2005, Oxford University Press (OUP)

Dr. Vicente Soriano
Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain

Article • Journal of Clinical Virology, May 2005, Elsevier

Dr. Vicente Soriano, Enrique J. Calderon
Estrategias terapéuticas en la infección por el virus de la inmunodeficiencia humana

Article • Medicina Clínica, May 2005, Elsevier

Dr. Vicente Soriano
Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration

Article • PLoS Medicine, April 2005, PLOS

Dr. Vicente Soriano
Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain

Article • Journal of Medical Virology, April 2005, Wiley

Enrique J. Calderon, Dr. Vicente Soriano
Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel

Article • AIDS, April 2005, Wolters Kluwer Health

Dr. Vicente Soriano
Interplay between hepatitis C, liver steatosis and antiretroviral therapy in HIV-infected patients

Article • AIDS, April 2005, Wolters Kluwer Health

Dr. Vicente Soriano
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine

Article • AIDS, April 2005, Wolters Kluwer Health

Dr. Vicente Soriano
Situación actual de la infección por el VIH-2 y el HTLV-1/2 en España: luces y sombras

Article • Medicina Clínica, April 2005, Elsevier

Dr. Vicente Soriano
Differential Upregulation of CD38 on Different T-Cell Subsets May Influence the Ability to Reconstitute CD4+ T Cells Under Successful Highly Active Antiretroviral Therapy

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2005, Wolters Kluwer Health

Dr. Vicente Soriano
Hepatitis C Viremia in HIV/HCV-Coinfected Patients: Lower Levels in Presence of Chronic Hepatitis B

Article • HIV Clinical Trials, April 2005, Taylor & Francis

Dr. Vicente Soriano
Influence of HTLV-2 infection on hepatitis C virus replication in HIV-positive patients

Article • Journal of Clinical Virology, April 2005, Elsevier

Dr. Vicente Soriano
Relationship between drug resistance mutations, plasma viremia, and CD4+T-cell counts in patients with chronic HIV infection

Article • Journal of Medical Virology, March 2005, Wiley

Dr. Vicente Soriano
Regulación de la transcripción en los diferentes subtipos del VIH-1

Article • Enfermedades Infecciosas y Microbiología Clínica, March 2005, Elsevier

Dr. Vicente Soriano
Risks and benefits of antiretroviral therapy in HIV–HCV co-infected patients

Article • Journal of Hepatology, March 2005, Elsevier

Dr. Vicente Soriano
Association of CCR5 Human Haplogroup E with Rapid HIV Type 1 Disease Progression

Article • AIDS Research and Human Retroviruses, February 2005, Mary Ann Liebert Inc

Dr. Vicente Soriano
Atazanavir: The Advent of a New Generation of More Convenient Protease Inhibitors

Article • HIV Clinical Trials, February 2005, Taylor & Francis

Dr. Vicente Soriano
Estimated Extent of Cross-Resistance to Ritonavir-Boosted Protease Inhibitors Among Protease Inhibitors-Experienced Patients: Implications for Tipranavir Use

Article • AIDS Patient Care and STDs, February 2005, Mary Ann Liebert Inc

Dr. Vicente Soriano
Hepatitis C y VIH en prisiones españolas

Article • Enfermedades Infecciosas y Microbiología Clínica, February 2005, Elsevier

Dr. Vicente Soriano
Natural history of Hymenoptera venom allergy in Eastern Spain

Article • Clinical & Experimental Allergy, February 2005, Wiley

Dr. Vicente Soriano
Heterogeneous nature of HIV-1 recombinants spreading in Spain

Article • Journal of Medical Virology, January 2005, Wiley

Dr. Vicente Soriano
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients

Article • Journal of Medical Virology, January 2005, Wiley

Dr Alejandro Vallejo, Dr. Vicente Soriano
Hepatotoxicity of Antiretrovirals

Article • Drug Safety, January 2005, Springer Science + Business Media

Dr. Vicente Soriano
Hepatitis C Virus (HCV) Genotypes and Disease Progression in HIV/HCV‐Coinfected Patients

Article • The Journal of Infectious Diseases, January 2005, Oxford University Press (OUP)

Dr. Vicente Soriano
Predictive value of drug levels, HIV genotyping, and the genotypic inhibitory quotient (GIQ) on response to saquinavir/ritonavir in antiretroviral-experienced HIV-infected patients

Article • Journal of Medical Virology, January 2005, Wiley

Dr. Vicente Soriano
The Seroepidemiology of Human T-Lymphotropic Viruses

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2005, Wolters Kluwer Health

Dr. Vicente Soriano
Absceso cerebral en paciente inmunodeprimida

Article • Enfermedades Infecciosas y Microbiología Clínica, January 2005, Elsevier

Dr. Vicente Soriano
Short Communication: Benefits in the Lipid Profile after Substitution of Abacavir for Stavudine: A 48-Week Prospective Study

Article • AIDS Research and Human Retroviruses, December 2004, Mary Ann Liebert Inc

Dr. Vicente Soriano
Hepatocellular carcinoma in HIV-infected patients

Article • AIDS, November 2004, Wolters Kluwer Health

Dr Victor Asensi, Dr. Vicente Soriano
Avances en el diagnóstico y tratamiento de la infección por el virus de la hepatitis B

Article • Enfermedades Infecciosas y Microbiología Clínica, November 2004, Elsevier

Dr. Vicente Soriano
Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes

Article • Journal of Clinical Virology, November 2004, Elsevier

Dr. Vicente Soriano
Evidence for Differences in the Sexual Transmission Efficiency of HIV Strains with Distinct Drug Resistance Genotypes

Article • Clinical Infectious Diseases, October 2004, Oxford University Press (OUP)

Dr. Vicente Soriano
Prevalence of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis B and C viruses among immigrant sex workers in Madrid, Spain

Article • Journal of Medical Virology, October 2004, Wiley

Dr. Vicente Soriano
Comments on the review ‘Care of patients with hepatitis C and HIV co-infection’ by Soriano et al.

Article • AIDS, October 2004, Wolters Kluwer Health

Dr. Vicente Soriano
Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals

Article • Journal of Virological Methods, October 2004, Elsevier

Dr. Vicente Soriano
Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations

Article • AIDS, October 2004, Wolters Kluwer Health

Dr. Vicente Soriano
How effective is HAART in HCV and HIV coinfection?

Article • AIDS, October 2004, Wolters Kluwer Health

Dr. Vicente Soriano
Predictors of selection of K65R

Article • AIDS, October 2004, Wolters Kluwer Health

Dr. Vicente Soriano
Reply to Bruno et al.

Article • AIDS, October 2004, Wolters Kluwer Health

Dr. Vicente Soriano
Failure to Detect Human Immunodeficiency Virus Type 1 Superinfection in 28 HIV-Seroconcordant Individuals with High Risk of Reexposure to the Virus

Article • AIDS Research and Human Retroviruses, September 2004, Mary Ann Liebert Inc

Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu
Triple-Nucleoside Regimens versus Efavirenz

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2004, New England Journal of Medicine (NEJM/MMS)

Dr. Vicente Soriano
Resistance to HIV Protease Inhibitors: Mechanisms and Clinical Consequences

Article • Current Drug Metabolism, August 2004, Bentham Science Publishers

Dr. Vicente Soriano
New Hopes for HIV and HCV Coinfection in 2004

Article • HIV Clinical Trials, August 2004, Taylor & Francis

Dr. Vicente Soriano
Predictors of Virological Response to Atazanavir in Protease Inhibitor-Experienced Patients

Article • HIV Clinical Trials, August 2004, Taylor & Francis

Dr. Vicente Soriano
Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failure

Article • Journal of Medical Virology, July 2004, Wiley

Dr. Vicente Soriano
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes

Article • The Lancet, July 2004, Elsevier

Dr Maria Rosaria Capobianchi, Dr. Vicente Soriano
Short Communication: Liver Toxicity of Lopinavir-Containing Regimens in HIV-Infected Patients with or without Hepatitis C Coinfection

Article • AIDS Research and Human Retroviruses, July 2004, Mary Ann Liebert Inc

Dr. Vicente Soriano
Reply

Article • Clinical Infectious Diseases, June 2004, Oxford University Press (OUP)

Dr. Vicente Soriano
Predictors of Severe Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis C

Article • Clinical Infectious Diseases, June 2004, Oxford University Press (OUP)

Dr. Vicente Soriano
CD4+ T-Cell Gain With Nonnucleoside or Protease Inhibitors: Convenience May Not Always Be the Most Convenient

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, June 2004, Wolters Kluwer Health

Dr. Vicente Soriano
Enhanced HIV-specific immune responses in chronically HIV-infected patients receiving didanosine plus hydroxyurea

Article • AIDS, June 2004, Wolters Kluwer Health

Dr. Vicente Soriano
Impact of Chronic Hepatitis C on HIV-1 Disease Progression

Article • HIV Clinical Trials, June 2004, Taylor & Francis

Dr. Vicente Soriano
Tolerance of Didanosine as Enteric-Coated Capsules versus Buffered Tablets

Article • AIDS Patient Care and STDs, June 2004, Mary Ann Liebert Inc

Dr. Vicente Soriano
Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide

Article • AIDS, May 2004, Wolters Kluwer Health

Dr. Vicente Soriano
Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection

Article • AIDS, May 2004, Wolters Kluwer Health

Dr. Vicente Soriano
Hepatitis C Virus (HCV) Relapses after Anti-HCV Therapy Are More Frequent in HIV-Infected Patients

Article • AIDS Research and Human Retroviruses, April 2004, Mary Ann Liebert Inc

Dr. Vicente Soriano
Tenofovir-related nephrotoxicity in HIV-infected patients

Article • AIDS, April 2004, Wolters Kluwer Health

Dr. Vicente Soriano
Prevalencia de infección por virus de transmisión parenteral en consumidores actuales de heroína de 3 ciudades españolas

Article • Medicina Clínica, April 2004, Elsevier

Dr. Vicente Soriano
Simplificación de los regímenes antirretrovíricos. Una necesidad para garantizar el control de la infección por VIH a largo plazo

Article • Revista Clínica Española, April 2004, Elsevier

Dr. Vicente Soriano
Infecciones por VIH-2 y HTLV-I/II en España

Article • Enfermedades Infecciosas y Microbiología Clínica, March 2004, Elsevier

Dr Alejandro Vallejo, Dr. Vicente Soriano, Enrique J. Calderon
Are Fusion Inhibitors Active against All HIV Variants?

Article • AIDS Research and Human Retroviruses, March 2004, Mary Ann Liebert Inc

Dr. Vicente Soriano
Changes in Mitochondrial DNA Copy Number in Blood Cells from HIV-Infected Patients Undergoing Antiretroviral Therapy

Article • AIDS Research and Human Retroviruses, March 2004, Mary Ann Liebert Inc

Dr. Vicente Soriano
Prediction of Virological Response to Lopinavir/Ritonavir Using the Genotypic Inhibitory Quotient

Article • AIDS Research and Human Retroviruses, March 2004, Mary Ann Liebert Inc

Dr. Vicente Soriano
Prevalence of drug resistance genotypes causing broad cross-resistance to nucleos(t)ide analogues

Article • AIDS, March 2004, Wolters Kluwer Health

Dr. Vicente Soriano
Different Viral Rebound following Discontinuation of Antiretroviral Therapy in Cases of Infection with Viruses Carrying L74V or Thymidine-Associated Mutations

Article • Journal of Clinical Microbiology, February 2004, ASM Journals

Dr. Vicente Soriano
Analyzing Sleep Abnormalities in HIV‐Infected Patients Treated with Efavirenz

Article • Clinical Infectious Diseases, February 2004, Oxford University Press (OUP)

Dr. Vicente Soriano
CD38 Expression on CD8 T Lymphocytes as a Marker of Residual Virus Replication in Chronically HIV-Infected Patients Receiving Antiretroviral Therapy

Article • AIDS Research and Human Retroviruses, February 2004, Mary Ann Liebert Inc

Dr. Vicente Soriano
HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1

Article • AIDS, February 2004, Wolters Kluwer Health

Dr. Vicente Soriano
Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus–Infected Patients with Chronic Hepatitis C: A European Collaborative Study

Article • Clinical Infectious Diseases, January 2004, Oxford University Press (OUP)

Dr Victor Asensi, Dr. Vicente Soriano
Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations

Article • Journal of Viral Hepatitis, January 2004, Wiley

Dr Victor Asensi, Dr. Vicente Soriano
Care of patients with hepatitis C and HIV co-infection

Article • AIDS, January 2004, Wolters Kluwer Health

Dr. Vicente Soriano
Impact of Drug Levels and Baseline Genotype and Phenotype on the Virologic Response to Amprenavir/Ritonavir-Based Salvage Regimens

Article • AIDS Patient Care and STDs, January 2004, Mary Ann Liebert Inc

Dr. Vicente Soriano
Management of Chronic Hepatitis C in Patients Co-Infected with HIV

Article • Drug Safety, January 2004, Springer Science + Business Media

Dr. Vicente Soriano
Modifications in SENV DNA Detection and/or SENV Subtype Determination over a Prospective Follow-Up in a Cohort of HIV-Positive Patients: Is This a Moving Target?

Article • Intervirology, January 2004, Karger Publishers

Dr. Vicente Soriano
391 Association between HCV-specific CD8+ T cell responses and levels of viral replication in patients chronically infected with HCV

Article • Journal of Hepatology, January 2004, Elsevier

Dr. Vicente Soriano
262 Clinical presentation and outcome of hepatocellular carcinoma in HIV infected patients

Article • Journal of Hepatology, January 2004, Elsevier

Dr. Vicente Soriano
Hepatitis E in the south west of France in individuals who have never visited an endemic area

Article • Journal of Medical Virology, January 2004, Wiley

Dr. Vicente Soriano
Treatment of Chronic Hepatitis B in the Human Immunodeficiency Virus-Infected Patient: Present and Future

Article • Clinical Infectious Diseases, December 2003, Oxford University Press (OUP)

Dr. Vicente Soriano
Treatment of Chronic Hepatitis C in HIV-Infected Patients with Interferon α -2b Plus Ribavirin

Article • AIDS Research and Human Retroviruses, December 2003, Mary Ann Liebert Inc

Dr Victor Asensi, Dr. Vicente Soriano
Hydroxyurea plus Didanosine as Maintenance Therapy for HIV-Infected Patients on Long-Term Successful Highly Active Antiretroviral Therapy

Article • HIV Clinical Trials, December 2003, Taylor & Francis

Dr. Vicente Soriano
Long-Term Outcome of HIV-Infected Patients with Multinucleoside-Resistant Genotypes

Article • HIV Clinical Trials, December 2003, Taylor & Francis

Dr. Vicente Soriano
SENV Infection in HIV-Positive Patients: Prevalence, Subtype Characterization, and Impact on HIV Disease Progression

Article • AIDS Research and Human Retroviruses, December 2003, Mary Ann Liebert Inc

Dr. Vicente Soriano
Book Review

Article • Educational Studies, December 2003, Taylor & Francis

Dr. Vicente Soriano
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2003, New England Journal of Medicine (NEJM/MMS)

Dr. Vicente Soriano
Phenotype and Functional Characteristics of HIV-Specific Cytotoxic CD8+ T Cells in Chronically Infected Patients

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, November 2003, Wolters Kluwer Health

Dr. Vicente Soriano
Diarrhea Related to Lopinavir Is Most Often Mild and Not Related to Plasma Drug Levels

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, October 2003, Wolters Kluwer Health

Dr. Vicente Soriano
Role of Baseline Human Immunodeficiency Virus Genotype as a Predictor of Viral Response to Tenofovir in Heavily Pretreated Patients

Article • Journal of Clinical Microbiology, September 2003, ASM Journals

Dr. Vicente Soriano
Toxicidad mitocondrial de los antirretrovirales: diagnóstico y monitorización

Article • Medicina Clínica, September 2003, Elsevier

Dr. Vicente Soriano
Correlation Between Lopinavir Plasma Levels and Lipid Abnormalities in Patients Taking Lopinavir/Ritonavir

Article • AIDS Patient Care and STDs, September 2003, Mary Ann Liebert Inc

Dr. Vicente Soriano
Gynecomastia in HIV-Infected Patients Receiving Antiretroviral Therapy

Article • AIDS Research and Human Retroviruses, September 2003, Mary Ann Liebert Inc

Dr. Vicente Soriano
Virus Load and Cytolitic Responses in Human Immunodeficiency Virus Infection: What Is Cause and What Is Effect

Article • The Journal of Infectious Diseases, September 2003, Oxford University Press (OUP)

Dr. Vicente Soriano
Distribution of Hepatitis B Virus Genotypes in HIV-Infected Patients with Chronic Hepatitis B: Therapeutic Implications

Article • AIDS Research and Human Retroviruses, August 2003, Mary Ann Liebert Inc

Dr. Vicente Soriano
Impact of Hepatitis C Virus (HCV) on Morbidity and Mortality Rates among HIV-Infected Patients

Article • Clinical Infectious Diseases, August 2003, Oxford University Press (OUP)

Dr. Vicente Soriano
Replacement of Protease Inhibitors by Nevirapine or Efavirenz in Simplification and Rescue Interventions: Which Works Better?

Article • HIV Clinical Trials, August 2003, Taylor & Francis

Dr. Vicente Soriano
Can Drug Resistance Mutations Influence the Measurement of Plasma HIV-RNA by Different Viral Load Techniques?

Article • AIDS Patient Care and STDs, July 2003, Mary Ann Liebert Inc

Dr. Vicente Soriano
Superinfección por el virus de la inmunodeficiencia humana: implicaciones clínicas y biológicas

Article • Medicina Clínica, July 2003, Elsevier

Dr. Vicente Soriano
Indinavir Plasma Concentrations and Resistance Mutations in Patients Experiencing Early Virological Failure

Article • AIDS Research and Human Retroviruses, June 2003, Mary Ann Liebert Inc

Dr. Vicente Soriano
Transmission of HIV Type 1 through Blood Transfusion from an Antibody-Negative/p24 Antigen-Negative Donor

Article • AIDS Research and Human Retroviruses, June 2003, Mary Ann Liebert Inc

Dr. Vicente Soriano
Secuencias largas terminales repetidas de los retrovirus: estructura y función

Article • Medicina Clínica, June 2003, Elsevier

Dr. Vicente Soriano
Lamivudine Resistance in Human T-Cell Leukemia Virus Type 1 May Be Due to a Polymorphism at Codon 118 (V->I) of the Reverse Transcriptase

Article • Antimicrobial Agents and Chemotherapy, May 2003, ASM Journals

Dr. Vicente Soriano
HIV-Positive Immigrants in the Canary Islands, Spain: Implications for Public Health in Europe

Article • HIV Clinical Trials, May 2003, Taylor & Francis

Dr. Vicente Soriano
Human immunodeficiency virus type 1 recombinant B/G subtypes circulating in Coimbra, Portugal

Article • Clinical Microbiology and Infection, May 2003, Elsevier

Dr. Vicente Soriano
Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

Article • AIDS, May 2003, Wolters Kluwer Health

Dr. Vicente Soriano
Rate, Causes, and Clinical Implications of Presenting with Low CD4+ Cell Counts in the Era of Highly Active Antiretroviral Therapy

Article • AIDS Research and Human Retroviruses, May 2003, Mary Ann Liebert Inc

Dr. Vicente Soriano
Histological damage in liver biopsy specimens from 492 HIV-HCV co-infected patients: A European collaborative study

Article • Journal of Hepatology, April 2003, Elsevier

Dr Victor Asensi, Dr. Vicente Soriano
Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy

Article • AIDS, April 2003, Wolters Kluwer Health

Dr. Vicente Soriano
Is Treatment Failure for Hepatitis C Virus Infection in HIV-Positive Drug Users Associated With a Shift in HCV Genotypes?

Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2003, Wolters Kluwer Health

Dr. Vicente Soriano
Low rate of HIV-1 codon 215 revertants in antiretroviral-experienced patients

Article • AIDS, April 2003, Wolters Kluwer Health

Dr. Vicente Soriano
Performance of drug resistance assays in testing HIV-1 non-B subtypes

Article • Clinical Microbiology and Infection, April 2003, Elsevier

Dr. Vicente Soriano
Hepatitis C virus (HCV) relapses following the end of anti-HCV therapy are more frequent in HIV-coinfected patients

Article • Journal of Hepatology, April 2003, Elsevier

Dr. Vicente Soriano
Predictive value of early virological response (12 weeks) to pegylated interferon plus ribavirin in HIV-HCV coinfected patients

Article • Journal of Hepatology, April 2003, Elsevier

Dr. Vicente Soriano
Changes in the Human Immunodeficiency Virus p7-p1-p6 gag Gene in Drug-Naive and Pretreated Patients

Article • Journal of Clinical Microbiology, March 2003, ASM Journals

Dr. Vicente Soriano
Avascular Necrosis in HIV-Infected Patients Receiving Antiretroviral Treatment: Study of Seven Cases

Article • HIV Clinical Trials, March 2003, Taylor & Francis

Dr. Vicente Soriano

Showing 1,000 Stories.

Search

Main menu

Discover

Subjects on Kudos

Services and resources

Admin

Contact

All Stories

Contact

Social

All Stories